ciprofloxacin has been researched along with zithromax in 375 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 44 (11.73) | 18.2507 |
| 2000's | 85 (22.67) | 29.6817 |
| 2010's | 155 (41.33) | 24.3611 |
| 2020's | 91 (24.27) | 2.80 |
| Authors | Studies |
|---|---|
| Barecki, M; Casciano, CN; Clement, RP; Johnson, WW; Lew, K; Wang, E | 1 |
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Dahl, EL; Rosenthal, PJ | 1 |
| Appelbaum, PC; Bogdanovich, T; Clark, C; Dewasse, B; Ednie, L; McGhee, P; Smith, K | 1 |
| Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
| Collins, MT; Shin, SJ | 1 |
| Appelbaum, PC; Ednie, LM; Hawser, S; Lociuro, S; Smith, K | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
| Crabb, DM; Duffy, LB; Waites, KB | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Juan, C; Maciá, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL | 1 |
| Beeton, ML; Chalker, VJ; Kotecha, S; Maxwell, NC; Spiller, OB | 1 |
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 1 |
| Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P | 1 |
| Goy, G; Greub, G | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Ekambaram, R; Raghunathan, M; Raghunathan, R; Rao, SS | 1 |
| Hamasuna, R; Jensen, JS; Osada, Y | 1 |
| Kamal, N; Shafer, WM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Ambrose, PG; Bassett, J; Beaudry, A; Bhavnani, SM; Critchley, I; Gill, SC; Heine, HS; Janjic, N; Li, J; Miller, L; Rubino, CM; Stone, KC | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Gunell, M; Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Siitonen, A | 1 |
| Fuller, CA; McGannon, CM; Weiss, AA | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Biedenbach, DJ; Hammerschlag, MR; Jones, RN; Kohlhoff, SA; Roblin, PM | 1 |
| Fajdetić, A; Mutak, S; Pavlović, D | 1 |
| Allen, VG; Farrell, DJ; Lo, S; Low, DE; Melano, RG; Perusini, SJ; Rebbapragada, A; Tan, J; Tijet, N; Towns, L | 1 |
| Black, T; Daubaras, DL; Mansoor, UF; McNicholas, P; Orth, P; Reddy, PA; Siddiqui, MA; Vitharana, D | 1 |
| Arena, ME; Bardón, A; Gilabert, M; Ramos, AN; Schiavone, MM | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Mutak, S; Pavlović, D | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Steenbergen, J; Tanaka, SK; Villano, S | 1 |
| Kimmins, S; Mutak, S; Pavlović, D | 1 |
| Bojkovic, J; Dean, CR; Dobler, M; Dzink-Fox, J; Glick, M; Hamann, LG; Kerrigan, J; Lanieri, L; Lenoir, F; Lilly, MD; Liu, E; Lu, Y; McKenney, D; Nunez, J; Osborne, C; Parker, DT; Patnaik, A; Peng, Y; Piizzi, G; Ranjitkar, S; Sprague, ER; Tommasi, R; Wang, B; Wang, H; Wattanasin, S; Xie, L; Yang, X; Yu, D | 1 |
| Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M | 1 |
| Guo, H | 1 |
| Cushman, M; Fan, BZ; Han, X; Kong, FS; Li, YX; Liang, JH; Lv, W; Ma, CX; Tian, JC | 1 |
| Cushman, M; Fan, BZ; Guo, SY; Kong, FS; Li, XM; Li, YX; Liang, JH; Lv, W; Zhang, J | 1 |
| Aldrich, C; Brody, S; Cushman, M; Fan, BZ; Hiasa, H; Liang, JH; Lv, W; Yang, ZY | 1 |
| Amada, H; Endo, M; Hitaka, K; Kamitani, M; Masuko, A; Mihara, Y; Mima, M; Ohtake, N; Sugiyama, H; Takata, I; Takeuchi, T; Tamura, Y; Tanaka-Yamamoto, N; Ushiyama, F; Wada, R | 1 |
| Chang, YQ; Chen, WM; Hou, JS; Lin, J; Liu, J; Miao, ZY; Peng, LJ; Sun, PH; Zhang, XY | 1 |
| Bhando, T; Brown, ED; Carfrae, L; Ellis, MJ; Johnson, JW; MacNair, C; Magolan, J; Piquette, ZA; Ritchie, NE; Saliba, P | 1 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Carper, HT; Frank, MO; Mandell, GL; Sullivan, GW | 1 |
| Armstrong, D; Brown, IN; Brown, S; Dale, JW; Edwards, FF; Felder, MS; Ollar, RA | 1 |
| Børsum, T; Dannevig, L; Melby, K; Størvold, G | 1 |
| Brunham, R; Chubb, H; Ronald, A; Slaney, L | 1 |
| Girard, AE; Girard, D; Retsema, JA | 1 |
| Gray, RH; Quinn, T; Wawer, MJ | 1 |
| Innes, J; Pithie, A; Steven, N; Wood, M | 1 |
| Kosunen, TU; Rautelin, H; Renkonen, OV | 1 |
| Oz, HS; Retsema, J; Tanowitz, HB; Wasserman, S; Weiss, LM; Wittner, M | 1 |
| Butler, T; Girard, AE | 1 |
| Ikerd, TR; Koletar, SL | 1 |
| Amato, S; Echeverria, P; Hoge, CW; Kuschner, RA; Olafson, RP; Pitarangsi, C; Sadoff, JC; Taylor, DN; Thomas, RJ; Trofa, AF | 1 |
| Kluytmans, JA; Stolz, E; van Rijsoort-Vos, JH; Verbrugh, HA | 1 |
| Nix, DE; Oh, YK; Straubinger, RM | 1 |
| Arness, MK; Echeverria, P; Jackson, LR; LeBron, C; Murphy, GS; Pitarangsi, C | 1 |
| Mann, RD; Pearce, GL; Wilton, LV | 1 |
| Abeck, D; Ballard, RC | 1 |
| Besednova, NN; Shubin, FN; Zaĭtseva, EA | 1 |
| Conte, JE; Duncan, S; Golden, J; Lin, E; McKenna, E; Zurlinden, E | 1 |
| Kurbel, S; Vranes, J; Zagar, Z | 1 |
| Branley, J; Gottlieb, T; Wolfson, C | 1 |
| Bennish, ML; Dhar, U; Khan, WA; Salam, MA; Seas, C | 1 |
| Andrews, JM; Boswell, F; Brenwald, NP; Wise, R | 1 |
| Barbarini, D; Bono, L; Carretto, E; Marone, P; Telecco, S | 1 |
| Brajac, I; Gruber, F; Grubisic-Greblo, H; Jonjic, A; Lenkovic, M; Stasic, A | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Jepras, RI; Paul, FE; Pearson, SC; Wilkinson, MJ | 1 |
| Muszynski, MJ; Rajyaguru, JM | 1 |
| Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC | 1 |
| Fichera, ME; Roos, DS | 1 |
| Echeverria, P; Gambel, JM; Hoge, CW; Pitarangsi, C; Srijan, A | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
| Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK | 1 |
| Fortney, K; Hiltke, TJ; Hood, AF; Katz, B; O'Mara, EM; Shoup, RE; Sorensen, SJ; Spinola, SM; Thornton, AC | 1 |
| Berkley, S; Brookmeyer, R; Gray, RH; Kelly, R; Kiwanuka, N; Li, C; Lutalo, T; McNairn, D; Nalugoda, F; Paxton, L; Quinn, TC; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ | 1 |
| Christopherson, RI; Rieckmann, KH; Yeo, AE | 1 |
| Bouchillon, S; Johnson, J; Pontani, D; Washton, H | 1 |
| Brown, FM; Butler, T; Frenck, RW; Girgis, NI; Khakhria, R; Sultan, Y; Tribble, D | 1 |
| Dart, JK; Horgan, SE; Matheson, MM; McLOUGHLIN-Borlace, L | 1 |
| Akman, M; Arseven, O; Aydin Tosun, G; Erelel, M; Erk, M; Göylüsün, V; Gür, A; Ilvan, A; Koşar, F; Müsellim, B; Oztürk, S; Soysal, F; Türker, H; Tutluoglu, B; Umut, S; Unutmaz, S; Vahapoglu, H; Yildirim, N; Yilmaz Kuyucu, T; Yilmaz, N | 1 |
| Aleman, GM; Dunne, MW; Oundo, J; Petersen, L; Shanks, GD; Smoak, BL; Waiyaki, PG | 1 |
| Daschner, FD; Engels, I; Frank, U; Jonas, D | 1 |
| Mizen, L | 1 |
| Martinón Sánchez, J; Martinón Torres, F; Rodríguez Núñez, A | 1 |
| Dillon, JA; Li, H; Prabhakar, P; Ruben, M; Sealy, J | 1 |
| García Merino, J; González de Aledo Linos, A | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Gaillat, J | 1 |
| Brown, A; Camara, B; Castor, D; Furlonge, C; Jolly, PE; Prabhakar, P; Rao, A; Weiss, H | 1 |
| Danziger, LH; Jung, R; Pendland, SL | 1 |
| Connolly, CA; Karim, SS; Kharsany, AB; Rustomjee, R | 1 |
| Carryn, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F | 1 |
| Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL | 1 |
| Braun, J; Sieper, J | 1 |
| Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Forster, GE; Gibb, AM; McManus, T | 1 |
| Carryn, S; Seral, C; Tulkens, PM; Van Bambeke, F | 1 |
| Fernández-Cuenca, F; Martínez-Martínez, L; Pascual, A; Perea, EJ | 1 |
| Kusaba, N; Yoshida, H | 1 |
| Banaszak, A; Begovac, J; Krhen, I; Schönwald, S; Skerk, V; Strapac, Z; Strugar, J; Tomas, M; Vrsalovic, R; Vukovic, J | 1 |
| Seral, C; Tulkens, PM; Van Bambeke, F | 1 |
| Dillon, JA; Li, H; Llanes, R; Llop, A; Ramirez-Arcos, S; Ruben, M; Sosa, J | 1 |
| Lobzin, IuV; Pozniak, AL; Volzhanin, VM | 1 |
| Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S | 1 |
| Abu-Elyazeed, R; Clemens, JD; El-Gendy, A; Frenck, RW; Pittner, BT; Putnam, SD; Rao, MR; Riddle, MS; Savarino, SJ; Taha, NN; Wierzba, TF | 1 |
| Choo, CM; Lim, T; Lim, YS; Ngan, CC; Toh, GL | 1 |
| Michot, JM; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F | 1 |
| Bewley, KR; Dowsett, B; Lever, MS; Lloyd, G | 1 |
| Komorsky-Lovrić, S; Nigović, B | 1 |
| Chaudhary, C; Das, AK; Hasan Chaudhary, FA; Hossain, A; Kansaker, P; Karki, N; Malla, S; Neilsen, G; Pandy, AR; Rahman, M; Ross, JL | 1 |
| Lück, PC; Steinert, M | 1 |
| Appelbaum, PC; Bozdogan, B; Choi, DR; Credito, K; Dewasse, B; Kosowska-Shick, K; Lin, G; McGhee, P; Pankuch, GA; Ryu, JM | 1 |
| Enders, M; Regnath, T; Turnwald-Maschler, A | 1 |
| Bos, JC; Prins, JM; Schultsz, C; Speelman, P; Vandenbroucke-Grauls, CM | 1 |
| Ahmed, S; Bennish, ML; Karim, MM; Khan, WA; Saha, D; Salam, MA | 1 |
| Goh, BT; Rackstraw, S; Viswalingam, ND | 1 |
| Blau, H; Fabian, I; Halperin, D; Klein, K; Shalit, I | 1 |
| Haggerty, CL; Ness, RB | 1 |
| Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA | 1 |
| Buxbaum, A; Georgopoulos, A; Graninger, W; Kratzer, C; Macfelda, K | 1 |
| Erkin, G; Isik, SR; Kalyoncu, AF; Karakaya, G | 1 |
| Ceriani, I; de Eguileor, M; Del Nero, A; Magri, V; Mangiarotti, B; Marras, E; Montanari, E; Perletti, G; Trinchieri, A; Vral, A; Zirpoli, P | 1 |
| Ceriani, I; Magri, V; Marras, E; Perletti, G; Trinchieri, A | 1 |
| Baqui, AH; El Arifeen, S; Nair, GB; Rahman, M; Rashid, H; Sack, DA; Shoma, S; Siddique, AK | 1 |
| Day, M; de Pinna, E; Jones, J; Lawrence, J; Threlfall, EJ | 1 |
| Aoshima, M; Goto, H; Ishii, H; Kato, A; Kato, J; Kurai, D; Mikura, S; Saraya, T; Shimura, C; Takata, S; Wada, H; Watanabe, M; Yamada, A; Yamamoto, M; Yasutake, T; Yokoyama, T | 1 |
| Alhede, M; Bjarnsholt, T; Givskov, M; Høiby, N; Jensen, PO; Phipps, R; Rasmussen, TB; Skindersoe, ME; Tolker-Nielsen, T; Yang, L | 1 |
| Hansen, C; Olsen, KE; Pedersen, MG; Persson, S; Riise, E | 1 |
| Bingen, E | 1 |
| Cohen, R; Gendrel, D | 1 |
| Bormann, AM; Boulware, DR | 1 |
| Abeijon, C; Donohue-Rolfe, A; Krautz-Peterson, G; Parry, N; Sevo, M; Tzipori, S; Zhang, Q | 1 |
| Arbogast, PG; Cooper, WO; Dudley, JA; Dyer, SM; Gideon, PS; Hall, KS; Hernandez-Diaz, S; Kaltenbach, LA; Ray, WA | 1 |
| Liu, YN; Wang, D; Wang, Y | 1 |
| Das, S; Faridi, MM; Gupta, P; Kaushik, JS | 1 |
| Cao, JP; Chen, SX; Jiang, XG; Wu, L | 1 |
| Herchline, TE; Inkrott, BP | 1 |
| Chang, CL; Choi, GE; Kang, JE; Kim, JM; Kim, KH; Lee, EY; Tateda, K; Yamaguchi, K | 1 |
| Davis, DK; Donnenfeld, ED; Maddula, S; Mamalis, N; Ness, PJ; Olson, RJ; Werner, L | 1 |
| Halden, RU; McClellan, K; Walters, E | 1 |
| Chatterjee, S; DuPont, HL; Gurleen, K; Jafri, S; Jiang, ZD; McKenzie, R; Nandy, RK; Ouyang-Latimer, J; Ramamurthy, T; Rodriguez, S; Steffen, R; VanTassel, A | 1 |
| Castillo, R; Cepeda, D; Chacaltana, J; Espinosa, B; Espinoza, N; González, S; Guillen, A; Hall, ER; Maves, RC; Meza, R; Núñez, G; Sánchez, L | 1 |
| Abele-Horn, M; Frosch, M; Müller, S; Tappe, D; Valenza, G | 1 |
| Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
| Magri, V; Markotić, A; Marras, E; Montanari, E; Naber, KG; Perletti, G; Restelli, A; Škerk, V | 1 |
| Chen, XS; Dai, XQ; Pearline, RV; Unemo, M; Xiang, Z; Yin, YP; Yuan, LF | 1 |
| Dujnić Spoljarević, T; Kolumbić Lakos, A; Kovacic, D; Magri, V; Maleković, G; Markotić, A; Pasini, M; Perletti, G; Skerk, V | 1 |
| Bauwens, A; Bielaszewska, M; Idelevich, EA; Karch, H; Mellmann, A; Peters, G; Schaumburg, F; Zhang, W | 1 |
| Alary, M; Asamoah-Adu, C; Demers, E; Dzokoto, A; Khonde, N; Labbé, AC; Mabey, D; Mayaud, P; Méda, H; Pépin, J | 1 |
| Dumke, R; Proesmans, M; Saegeman, V | 1 |
| Ayeni, IV; Calver, G | 1 |
| Ahmad, T; Mandalia, T; Shepherd, NA; So, K | 1 |
| Arriola, CS; Bernal, M; Calampa, C; Camiña, M; Casapia, M; Chuquiray, N; Gregory, M; Guevara, J; Hall, E; Jones, F; Kasper, M; Lopez, M; Maves, R; Meza, R; Patiño, L; Perez, J; Pollett, S; Rocha, C; Rosenbaum, M; Salazar-Lindo, E; Tilley, D; Valencia, A; Zerpa, R | 1 |
| Anvari, V; Dillon, JA; Horsman, GB; Levett, PN; Thakur, SD; Vidovic, S | 1 |
| Ballesteros, AM; Benzaken, AS; Borthagaray, G; Carbajal, JL; Carvallo, ME; Cruz, OM; Dillon, JA; Galarza, P; Hernandez, AL; Payares, D; Starnino, S | 1 |
| Amornchai, P; An, KP; Baker, S; Carter, MJ; Chanpheaktra, N; Chheng, K; Day, NP; Duy, PT; Emary, K; Kumar, V; Moore, CE; Nga, TV; Parry, CM; Sona, S; Stoesser, NE; Wijedoru, L; Wuthiekanun, V | 1 |
| Adelson, ME; Balashov, S; Gygax, SE; Mordechai, E | 1 |
| Fernando, S; Gottlieb, T; Molland, JG | 1 |
| Elzir, L; Saliba, I | 1 |
| Bertrand, S; De Smet, B; Jacobs, JA; Kham, C; Lynen, L; Peetermans, WE; Phe, T; Vanhoof, R; Veng, CH; Vlieghe, ER | 1 |
| Balcells, ME; Cárdenas, C; García, P; Giesen, L; González, S; Uribe, P | 1 |
| Bolan, G; del Rio, C; Hall, G; Holmes, KH; Holmes, KK; Hook, EW; Kirkcaldy, RD; Papp, J; Soge, O; Weinstock, HS; Zaidi, A | 1 |
| Caceres, S; Caverly, L; Fratelli, C; Kim, SH; Malcolm, K; Moskowitz, S; Nichols, DP; Nick, JA; Poch, KR; Saavedra, M; Solomon, G; Taylor-Cousar, J | 1 |
| Anila, KR; Mathew, AP; Mohan, A; Nath, SR | 1 |
| Bouchrif, B; Elhani, D; Guibert, V; Harrois, D; Le Hello, S; Sontag, L; Weill, FX; Zerouali, K | 1 |
| Dorin, M; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M | 1 |
| de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R | 1 |
| Dillon, JA; Horsman, GB; Levett, PN; Thakur, SD | 1 |
| Gandhi, SV; Khan, M; Polli, JE; Rodriguez, W | 1 |
| Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R | 1 |
| Bukenya, J; Grosskurth, H; Hughes, P; Lewis, DA; Matovu, G; Vandepitte, J | 1 |
| Goessens, WH; Hassing, RJ; Mevius, DJ; Molhoek, N; Stricker, BH; van Genderen, PJ; van Pelt, W; Verbon, A | 1 |
| Biao, K; Chan, EW; Chen, S; Wong, MH; Yan, M | 1 |
| Furubayashi, K; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M | 1 |
| Frigo, N; Khairullin, R; Kubanov, A; Kubanova, A; Semina, V; Solomka, V; Unemo, M; Vorobyev, D | 1 |
| Patsche, CB; Svensson, E; Wejse, C | 1 |
| Chen, X; Dai, XQ; Gan, Q; Huang, YJ; Li, W; Liang, M; Wei, JP; Yin, Y; Yu, RX; Zhu, BY | 1 |
| Antonetti, R; Bonanno, C; Busetti, M; Carannante, A; Cava, MC; Cusini, M; D'Antuono, A; Dal Conte, I; Gaino, M; Ghisetti, V; Giraldi, C; Impara, G; Latino, MA; Matteelli, A; Mencacci, A; Prignano, G; Renna, G; Stefanelli, P; Vocale, C | 1 |
| Brunner, A; Karpati, S; Marschalko, M; Mihalik, N; Nemes-Nikodem, E; Ostorhazi, E | 1 |
| Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
| Akter, M; Alemu, W; Bardhan, PK; Clemens, JD; Faruque, SM; Islam, MS; Islam, S; Jambai, A; Kamara, A; Khan, AI; Mahmud, ZH; Rhodes, FC; Talukder, KA; Wurie, IM; Zaman, RU | 1 |
| Chan, KA; Chang, CH; Chou, HW; Lai, CL; Lai, MS; Wang, JL | 1 |
| Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M | 1 |
| Bishayi, B; Dey, I; Dey, S; Mahanti, S; Majhi, A | 1 |
| DuPont, HL; Hill, DR; Steffen, R | 1 |
| Chhibber, S; Harjai, K; Saini, H | 2 |
| Lahra, MM | 1 |
| He, Q; Li, Y; Liu, X; Wang, Z; Zhang, B | 1 |
| Bala, M; Bhargava, A; Ramesh, V; Singh, V | 1 |
| Cole, M; Fredlund, H; Jacobsson, S; Ringlander, J; Unemo, M; Wiggins, C | 1 |
| Azzam, O; Crowe, A; Pawar, B; Sajiv, C | 1 |
| Barbé, B; Bertrand, S; Ceyssens, PJ; Falay, D; Jacobs, J; Kalonji, LM; Kuijpers, L; Lunguya, O; Mattheus, W; Muyembe, JJ; Ngbonda, D; Phoba, MF; Post, A; Van Geet, C; Verhaegen, J | 1 |
| Babics, A; Roussellier, P | 1 |
| Alm, RA; Le, WJ; Li, S; Liu, YR; Mueller, JP; Rice, PA; Su, XH; Wan, C; Wang, BX | 1 |
| Al-Shahib, A; Alexander, S; Chisholm, SA; Fifer, H; Lythgow, K; Schaefer, U; Tripodo, F; Wilson, J | 1 |
| Lübbert, C | 1 |
| Enriquez, RP; Lahra, MM | 3 |
| Cheng, ZJ; Li, S; Liu, WY; Sun, ZY; Tian, L; Xiang, X; Yu, WT; Zhang, WQ; Zhu, XH | 1 |
| Ignatius, R; Mertes, T; Regnath, T | 1 |
| Brunner, A; Jeney, C; Karpati, S; Marschalko, M; Nemes-Nikodem, E; Ostorhazi, E; Szabo, D | 1 |
| Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N | 1 |
| Bekal, S; Cornut, G; Gaudreau, C; Marchand-Senecal, X; Pilon, PA | 1 |
| Luo, Q; Shi, C; Wang, X; Wu, J; Yu, N | 1 |
| Alcaraz, I; Caumes, E; Dupin, N; Janier, M; Maatouk, I; Timsit, FJ | 1 |
| Misra, R; Prasad, KN | 1 |
| Araya, P; Borthagaray, G; Carvallo, ME; Corredor, AH; Dillon, JR; Galarza, P; Hernandez, AL; Payares, D; Sanabria Cruz, OM; Thakur, SD | 1 |
| Bodík, I; Fáberová, M; Grabic, R; Ivanová, L; Mackuľak, T | 1 |
| Cole, K; Cole, MJ; Crook, DW; De Silva, D; Demczuk, W; Eyre, DW; Grad, YH; Martin, I; Mulvey, MR; Paul, J; Peters, J; Peto, TEA; Walker, AS | 1 |
| Andrzejewska, M; Klawe, JJ; Spica, D; Szczepanska, B | 1 |
| Althaus, CL; Desilvestro, V; Foerster, S; Hathaway, LJ; Unemo, M | 1 |
| Chakanyuka Musanhu, C; Gudza-Mugabe, M; Gwanzura, L; Latif, AS; Machiha, A; Ndowa, F; Shukusho, FD; Tarupiwa, A; Unemo, M; Wi, T | 1 |
| Jiang, FX; Lan, Q; Le, WJ; Su, XH | 1 |
| Katz, AR; Kersh, EN; Kirkcaldy, RD; Komeya, AY; Kunimoto, GY; Maningas, EV; O'Brien, PS; O'Connor, NP; Papp, JR; Sato, DT; Soge, OO; Tomas, JE; Wasserman, GM; Whelen, AC | 1 |
| Adams, EJ; Christensen, H; Fifer, H; McAdams, D; McDonnell, A; Turner, KM; Woodford, N | 1 |
| Barnett, ED; Benoit, CM; Chen, LH; Hamer, DH; Han, PV; Jentes, ES; MacLeod, WB; Stoney, RJ; Wilson, ME | 1 |
| Li, R; Liu, A; Zhao, L; Zhao, S | 1 |
| Baird, RW; Beaman, M; Buckley, C; Chen, M; Donovan, B; Fairley, CK; Freeman, K; Guy, R; Hogan, T; Kaldor, JM; Karimi, M; Kundu, RL; Lahra, MM; Limnios, A; Regan, DG; Ryder, N; Su, JY; Trembizki, E; Ward, J; Whiley, DM | 1 |
| Tribble, DR | 1 |
| Amato-Gauci, AJ; Cole, MJ; Jacobsson, S; Spiteri, G; Tripodo, F; Unemo, M; Woodford, N | 1 |
| Brown, JD; Franklin, N; Hazelton, B; Howard, P; O'Sullivan, M; Reinten, T; Sheppeard, V; Willcox, SJ | 1 |
| Chesson, HW; Gift, TL; Grad, YH; Hsu, K; Salomon, JA; Tuite, AR | 1 |
| Dillon, JR; Horsman, GB; Levett, PN; Thakur, SD | 1 |
| Alcala, A; Brubaker, J; Chakraborty, S; DeNearing, B; Gariepy, CL; Guerry, P; Gutierrez, RL; Harro, C; Jaep, K; Laird, RM; Maue, AC; Mochalova, Y; Poly, F; Porter, CK; Riddle, MS; Rimmer, JE; Sack, DA; Talaat, KR; Tribble, DR | 1 |
| Allan-Blitz, LT; Hemarajata, P; Humphries, RM; Klausner, JD; Segura, ER; Wynn, A | 1 |
| Demczuk, W; Haldane, D; Hoang, L; Labbé, AC; Lefebvre, B; Martin, I; Mulvey, MR; Naidu, P; Peterson, SW; Wylie, J | 1 |
| Bremer, V; Buder, S; Dudareva, S; Guhl, E; Jansen, K; Kohl, PK; Loenenbach, A; Nikisins, S; Sailer, A | 1 |
| Fabiánová, K; Jakubů, V; Urbášková, P; Zavadilová, J | 1 |
| Abulreesh, HH; Ahmad, I; Khan, JA; Qais, FA; Rathore, RS | 1 |
| Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B | 1 |
| Alcala, A; Brubaker, J; Crofts, AA; Davies, BW; DeNearing, B; Ewing, CP; Guerry, P; Gutierrez, RL; Harro, C; Jaep, K; Kuroiwa, JM; Laird, RM; Maue, AC; McCoy, AJ; Poly, FM; Porter, CK; Ramakrishnan, A; Riddle, MS; Rimmer, JE; Sack, D; Talaat, KR; Trent, MS; Tribble, DR | 1 |
| Durkin, HG; Hammerschlag, MR; Joks, R; Kohlhoff, S; Norowitz, YM; Smith-Norowitz, TA; Weaver, D | 1 |
| Bazzo, ML; Benzaken, AS; Ferreira, WA; Franchini, M; Gaspar, PC; Golfetto, L; Pires, AF; Ramos, MC; Unemo, M | 1 |
| Araya Rodriguez, P; Borthagaray, G; Carvallo, MET; Chiappe, M; Corredor, AH; Cruz, OMS; Dillon, JR; Galarza, P; Hernandez, AL; Martin, I; Martinez, MF; Moreno, JE; Payares, D; Sawatzky, P; Thakur, SD | 1 |
| El-Shafei, RA; Eladl, AH; Elkenany, RM | 1 |
| Booth, JG; Gröhn, YT; Lanzas, C; Love, WJ; Zawack, KA | 1 |
| Aanensen, DM; Abad, R; Abudahab, K; Bercot, B; Borrego, MJ; Cole, MJ; Crowley, B; Goater, R; Golparian, D; Harris, SR; Jacobsson, S; Sánchez-Busó, L; Spiteri, G; Stefanelli, P; Tripodo, F; Unemo, M; Yeats, CA | 1 |
| Kumar, K; O'Connor, G; Ogram, A; Sidhu, H | 1 |
| D'Angelo, E; O'Connor, G; Sidhu, H | 1 |
| Tayimetha, CY; Unemo, M | 1 |
| Asbell, PA; DeCory, HH | 1 |
| Kruse, J; O'Connor, G; Sidhu, H | 1 |
| Calado, J; Campos, MJ; Castro, R; Lopes, Â; Pereira, F; Rocha, M | 1 |
| Burga, R; Colston, JM; François, R; Kosek, MN; Paredes-Olortegui, M; Peñataro-Yori, P; Pisanic, N; Schiaffino, F | 1 |
| Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J | 1 |
| Bazan, F; Dosso, M; Faye-Ketté, H; Gbedé, BD; Kouamé, CE; Kouamé-Blavo, B; Ouattara, A; Unemo, M; Wi, T; Yao, AC; Yéo, A | 1 |
| McAvoy, D; O'Connor, G; Sidhu, H | 1 |
| Amato-Gauci, AJ; Cole, MJ; Day, MJ; Jacobsson, S; Spiteri, G; Unemo, M; Woodford, N | 1 |
| Adamopoulos, J; Baines, SL; Carter, GP; Chen, MY; Chow, EPF; Easton, M; Fairley, CK; Gonçalves da Silva, A; Holt, KE; Howden, BP; Ingle, DJ; Kirk, MD; Kwong, JC; Seemann, T; Stephens, N; Valcanis, M; Williamson, DA | 1 |
| Carr, GJ; Jacobson, RK; Notaro, MJ | 1 |
| Kim, CM; Kim, DM; Park, HR; Yun, NR | 1 |
| Boss, J; Chanthongthip, A; Dance, DAB; Newton, PN; Robinson, MT; Wuthiekanun, V | 1 |
| Cui, Y; Li, A; Ma, J; Wang, D; Wang, S; Zhang, W | 1 |
| Enriquez, RP; George, CRR; Lahra, MM | 1 |
| Amado Fernández, E; Losada Castillo, I; Malvar Pintos, A; Paz Montero, Ó; Pousa Ortega, Á; Purriños-Hermida, MJ | 1 |
| Jacqz-Aigrain, E; Leroux, S; Magréault, S; Storme, T; Touati, J | 1 |
| Chen, MY; Chow, EPF; De Petra, V; Denham, I; Fairley, CK; Howden, BP; Stevens, K; Williamson, DA | 1 |
| Barbé, B; Clare, S; Coomber, EL; de Block, T; Deborggraeve, S; Dougan, G; Falay, D; Harcourt, K; Heinz, E; Jacobs, J; Klemm, EJ; Kuijpers, L; Lees, EA; Lunguya, O; Mbuyi Kalonji, L; Ngbonda, D; Phoba, MF; Pickard, D; Sridhar, S; Van Puyvelde, S; Vandelannoote, K; Wheeler, NE | 1 |
| Elgaher, WAM; Haupenthal, J; Hirsch, AKH; Lababidi, N; Ofosu Kissi, E; Rades, T; Schneider, M; Schwarz, BC; Sigal, V | 1 |
| Allen, M; Cho, DY; Elder, JB; Grayson, JW; Koch, C; Lim, DJ; McCormick, JP; Mclemore, J; Rivers, N; Skinner, D; Thompson, HM; West, J; Woodworth, BA; Zhang, S | 1 |
| Majewska, A; Majewski, S; Malejczyk, M; Młynarczyk, G; Młynarczyk-Bonikowska, B | 1 |
| Amato-Gauci, AJ; Cole, MJ; Day, M; Jacobsson, S; Quinten, C; Spiteri, G; Unemo, M; Woodford, N | 1 |
| Aljayyoussi, G; Angus, B; Ardrey, A; Biagini, GA; Feasey, NA; Gibani, MM; Jin, C; Liu, X; Moore, M; Parry, CM; Pennington, SH; Pollard, AJ | 1 |
| Mandal, J; Mohanraj, RS; Mukhopadhyay, AK; Samanta, P | 1 |
| Amicizia, D; Iovine, M; Lai, PL; Lecini, E; Marchini, F; Micale, RT; Panatto, D; Pennati, BM; Zangrillo, F | 1 |
| Ben Abdelmoumen Mardassi, B; Ben Allaya, A; Boujemaa, S; Mardassi, H; Mlik, B | 1 |
| Mohapatra, PP; Padhi, L; Panda, SK; Sahoo, G | 1 |
| Gravesen, C; Judy, JD | 1 |
| Giebułtowicz, J; Harnisz, M; Korzeniewska, E; Kucharski, D; Nałęcz-Jawecki, G; Płaza, G | 1 |
| Day, M; Godbole, G; Goldblatt, J; Morris-Jones, S; Ward, A; Yusuf, M | 1 |
| Barbé, B; Deborggraeve, S; Falay, D; Hardy, L; Ingelbeen, B; Jacobs, J; Kalonji, LM; Lunguya, O; Ngonda, D; Phoba, MF; Tack, B; van der Sande, MAB; Van Puyvelde, S | 1 |
| Doilicho, N; Grant, M; Radcliffe, C | 1 |
| Li, T; Ma, X; Shi, W; Zhang, Y; Zheng, X | 1 |
| Ackhter, MM; Ahmed, T; Alam, T; Chisti, MJ; Dash, S; Golam Faruque, AS; Khan, SH; Parvin, I; Rahman, MW; Sarmin, M; Shahid, ASMSB; Shahrin, L; Shahunja, KM | 1 |
| Andermann, TM; Batzoglou, S; Bhatt, AS; Bishara, A; Culver, RN; Handy, C; Ji, HP; Kang, JB; Moss, EL; Tkachenko, E; Weng, Z; Wood, C; Zlitni, S | 1 |
| Armstrong, BH; George, CRR; Hogan, TR; Lahra, MM; Shoushtari, M | 1 |
| Dong, N; Du, X; Jia, L; Li, Y; Liang, B; Liu, H; Ma, H; Qiu, S; Song, H; Sun, Y; Wang, J; Wu, F; Xia, S; Yang, C; Yang, X; Zhao, J | 1 |
| Buder, S; Dudareva, S; Eckardt, M; Gassowski, M; Graeber, I; Guhl, E; Heuer, D; Jansen, K; Selb, R; Tamminga, T | 1 |
| Ayinala, S; Cho, DY; Grayson, JW; Lim, DJ; Skinner, D; Thompson, HM; Walz, CR; Woodworth, BA; Zhang, S | 1 |
| Alexander, D; Allen, V; Barairo, N; Demczuk, W; Hatchette, TF; Hoang, L; Lefebvre, B; Martin, I; Mulvey, MR; Naidu, P; Peterson, SW; Tomas, K; Trubnikov, M; Wong, T | 1 |
| Cole, MJ; Day, M; Ebeyan, S; Erskine, S; Golparian, D; Hadad, R; Jacobsson, S; Tan, LY; Unemo, M; Whiley, D | 1 |
| de Souza Carvalho-Wodarz, C; Lababidi, N; Lehr, CM; Montefusco-Pereira, CV; Schneider, M | 1 |
| Hogan, TR; Lahra, MM; Shoushtari, M | 1 |
| Baddour, M; El Achy, S; Essa, S; Essawy, M; Rafik, S; Raouf, M | 1 |
| Aanensen, D; Ahlstrand, J; Cole, MJ; Day, M; Golparian, D; Jacobsson, S; Sánchez-Busó, L; Unemo, M | 1 |
| Alcoceba, E; Arando, M; Bernal, S; Colomina, J; Idigoras, P; Leal-Negredo, Á; Martin-Saco, G; Martínez, O; Menéndez, B; Romero, B; Salmerón, P; Serra-Pladevall, J; Torreblanca, A; Viñado, B | 1 |
| Cole, MJ; Day, M; Jacobsson, S; Spiteri, G; Unemo, M | 1 |
| Baker, KS; Baker, S; Bengtsson, RJ; Cerdeira, L; Dallman, TJ; Hawkey, J; Holt, KE; Hunt, M; Ingle, DJ; Iqbal, Z; Jenkins, C; Paranagama, K; Thomson, NR; Weill, FX; Williamson, DA | 1 |
| Adediran, AA; Chen, JC; Collins, JP; Fialkowski, V; Francois Watkins, L; Friedman, CR; Fullerton, KE; Gharpure, R; Marsh, ZA; Meservey, EH; Schroeder, MN; Strysko, J; Wadhwa, A | 1 |
| Delarocque-Astagneau, E; Guillemot, D; Huynh, BT; Ramblière, L | 1 |
| Bai, F; Chen, S; Cheng, Z; Fan, Z; Jin, Y; Li, S; Liang, Y; Liu, H; Pan, X; Pletzer, D; Ren, H; Wang, P; Wu, W; Xu, C; Xu, J; Zhang, J; Zhang, Y; Zhou, J; Zhu, G | 1 |
| Bae, HS; O'Connor, G; Ogram, A; Sidhu, H; Yu, F | 1 |
| Chan, EW; Chen, K; Chen, S; Yang, C | 1 |
| Alberny, M; Armas, M; Barberà, MJ; Cornejo-Sánchez, T; Espinal, P; Fàbrega, A; González-López, JJ; Goterris, L; Larrosa, MN; Martín-González, H; Mir-Cros, A; Moreno-Mingorance, A; Pumarola, T; Raventós, A; Rodriguez, V; Serra-Pladevall, J; Viñado, B | 1 |
| Fifer, H; Findlater, L; Geffen Obregon, O; Gobin, M; Mohammed, H; Ross, J; Turner, KME | 1 |
| Ahmed, SM; Amin, MR; Das, SK; Hasan, MJ; Islam, MR; Kabir, A | 1 |
| Allen, GP; Deao, KM; Hill, SA; Schipelliti, SM; Tran, T | 1 |
| Bazzo, ML; Bettoni, S; Blaskovich, MAT; Blom, AM; Maziarz, K; Potempa, J; Ram, S; Stone, MRL; Unemo, M | 1 |
| Bonongwe, N; Chen, JS; Chikaonda, T; Cohen, MS; Golparian, D; Hobbs, MM; Hoffman, IF; Jere, E; Kamtambe, B; Krysiak, R; Massa, C; Mathiya, E; Matoga, M; Ndalama, B; Unemo, M | 1 |
| Chen, W; Feng, Z; Liao, Y; Lin, X; Qin, X; Tang, S; Wu, X; Xie, Q; Yu, Y; Zheng, H | 1 |
| Gratrix, J; Martin, I; Mulvey, M; Naidu, P; Pilkie, D; Prasad, E; Sawatzky, P; Singh, A; Smyczek, PA; Wong, T | 1 |
| Bettinetti, R; Cappelli, F; Fochi, I; Longoni, O; Palumbo, MT; Polesello, S; Rigato, J; Roscioli, C; Rusconi, M; Sala, A; Salerno, F; Stefani, F; Valsecchi, S | 1 |
| Abu-Raddad, LJ; Al Khal, A; Al Romaihi, HE; Al-Maslamani, M; Al-Thani, MH; Chemaitelly, H; Elmagboul, EBI; Puthiyottil, A; Unemo, M; Varghese, MK | 1 |
| Abirami, BS; Alexander, AP; Amladi, A; Anandan, S; Bakthavatchalam, YD; Bavdekar, A; De, A; Dutta, S; Evelyn Ebenezer, S; Gupta, M; Jacob, JJ; Jinka, DR; John, J; Kang, G; Kapil, A; Koshy, RM; More, D; Nagaraj, S; Nayakanti, RR; Perumal, SPB; Pragasam, AK; Ray, P; Rongsen-Chandola, T; Saigal, K; Sanghavi, S; Sethuvel, DPM; Shastri, J; Singh, A; Thomas, M; Veeraraghavan, B | 1 |
| Mandal, J; Mohanraj, RS | 1 |
| Hu, Y; Jiang, G; Liao, C; Wang, Y; Zhu, Q | 1 |
| Asbell, PA; Mah, FS; Sanfilippo, CM | 1 |
| Lendamba, RW; Mbeang Nguema, PP; Mombo, LE; Onanga, R | 1 |
| Barazzetti, FH; Bazzo, ML; de Albuquerque, VCB; de Melo Machado, H; Golfetto, L; Martins, JM; Santos, TMD; Scheffer, MC; Schörner, MA | 1 |
| Cole, MJ; Dillon, JR; Eremin, S; Escher, M; Galarza, P; Galas, M; Lahra, MM; Martin, I; Ndowa, F; Ramon-Pardo, P; Unemo, M; Weinstock, H; Wi, T | 1 |
| Bekal, S; Bernaquez, I; Gaudreau, C; Goyette, A; Pilon, PA; Yared, N | 1 |
| Amato-Gauci, AJ; Blumel, B; Cole, MJ; Day, MJ; Jacobsson, S; Kulishev, C; Sajedi, N; Spiteri, G; Unemo, M; van der Werf, MJ; Woodford, N | 1 |
| Cuadros, J; Galicia, P; Górgolas, M; Linares, M; Miguel-Benito, A; Pérez García, F; Ramos-Rincón, JM | 1 |
| Güler, N; Süleyman, A; Tamay, Z | 1 |
| Barrios-Cárdenas, YJ; Benites, C; Jorge-Berrocal, A; Mayta-Barrios, M; Melano, RG; Salazar-Quispe, F; Vargas-Herrera, N; Yagui, M | 1 |
| Jenjaroenpun, P; Nitayanon, P; Nokchan, N; Tribuddharat, C; Wongsurawat, T | 1 |
| Barceló, D; Borja, Á; de Alda, ML; Larreta, J; López-García, E; Postigo, C; Rodríguez, JG; Solaun, O; Zonja, B | 1 |
| Armstrong, BH; Hogan, TR; Lahra, MM | 1 |
| Arun, S; Chakraborty, P; Gaonkar, O; Neppolian, B; Xin, L; Zhang, G | 1 |
| Götz, HM; van Benthem, BH; van Dam, AP; Visser, M | 1 |
| Catherine Stanton, I; Hayes, A; Hugo Gaze, W; Kaye Murray, A; May Murray, L; Snape, J; Zhang, L | 1 |
| Goytia, M; Wadsworth, CB | 1 |
| Bykov, K; Fischer, MA; Gagne, JJ; Kattinakere-Sreedhara, S; Wang, J | 1 |
| Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
| Bai, L; Chen, S; Du, PC; Jia, HY; Lu, M; Wang, Y; Zhai, WS; Zhan, ZF | 1 |
| Carle, I; Fabre, L; Feldman, S; Fontanet, A; Frézal, L; Lefèvre, S; Lejay-Collin, M; Njamkepo, E; Pardos de la Gandara, M; Ruckly, C; Weill, FX; Yassine, I | 1 |
| Álvarez-Rodríguez, E; Arias-Estévez, M; Díaz-Raviña, M; Fernández-Calviño, D; Núñez-Delgado, A; Rodríguez-González, L; Santás-Miguel, V | 1 |
| Adamson, PC; Bristow, CC; Dickson, SP; Dillon, JA; Fryling, KE; Grad, YH; Klausner, JD; Le, HHL; Mitchev, N; Mlisana, K; Morris, S; Mortimer, TD; Murphy, SM; Ovalles Ureña, RM; Parmar, NR; Pascual, R; Soge, OO; Van Le, H; Wakatake, E; Wi, T | 1 |
| Bailey, LS; Basso, KB; Begum, Y; Brinkley, L; Cato, E; Creasy-Marrazzo, A; Kamat, M; Khan, AI; Nelson, EJ; Qadri, F; Rashid, MM; Saber, MM; Shapiro, BJ | 1 |
| Abdellati, S; De Baetselier, I; de Block, T; Elise Laumen, JG; González, N; Kenyon, C; S Manoharan-Basil, S; Van Dijck, C | 1 |
| Ahmad, M; Shah, N; Siddiqui, MA | 1 |
| Antonio, M; Awuor, AO; Badji, H; Doh, S; Focht, C; Hossain, MJ; Houpt, E; Jones, J; Jones, JCM; Juma, J; Kasumba, IN; Kotloff, KL; Liu, J; Nasrin, D; Nasrin, S; Ochieng, JB; Omore, R; Permala-Booth, J; Platts-Mills, JA; Powell, H; Roose, A; Sen, S; Sow, SO; Sugerman, CE; Tennant, SM; Verani, JR; Watson, N; Widdowson, MA; Zaman, SMA | 1 |
| Allen, H; Althaus, CL; Cole, MJ; Grad, YH; Heijne, JCM; Low, N; Riou, J; Unemo, M | 1 |
| Denny, JC; Forest, K; Gu, S; Larson, EA; Rajendiran, G; Tran, TC; Wilke, RA | 1 |
| Chasqueira, MJ; Cruz, C; Fernandes, F; Paixão, P; Rodrigues, L; Santos, R | 1 |
| Broner, S; Ciruela, P; Cruells, A; Esteve, S; Ferré, L; Herrero, M; Jané, M; Mendioroz, J | 1 |
| Dadwal, R; Gainder, S; Ghosh, AK; Gupta, P; Paul, S; Sethi, S; Shivaprakash, MR; Sood, S; Yadav, R | 1 |
| Langton Hewer, SC; Rowbotham, NJ; Smith, S; Smyth, AR; Yule, A | 1 |
| Bi, C; Cao, W; Li, X; Liang, J; Liu, W; Yu, Y; Zhang, X | 1 |
| Bercot, B; Chen, JS; Godreuil, S; Golparian, D; Hoffman, I; Jacobsson, S; Kakooza, F; Krysiak, R; Kularatne, R; Lamorde, M; Manabe, YC; Maseko, V; Matoga, M; Unemo, M; Wi, T | 1 |
| Cheng, WH; Ho, CH; Su, PY | 1 |
| Bhattarai, KH; Fang, H; Vestberg, N | 1 |
| Blouin, K; Defay, F; Ezin Aloffan, LND; Labbé, AC; Lefebvre, B; Perrault Sullivan, G; Trudelle, A | 1 |
| Qiu, S; Xiang, Y; Yang, C | 1 |
| Du, X; Han, Y; Li, X; Liu, H; Liu, M; Qiu, S; Song, H; Xiang, Y; Xu, X; Yang, C; Yang, H; Zhu, K | 1 |
| Hogan, TR; Lahra, MM; Van Hal, S | 1 |
| Bamford, C; Gigi, R; Jung, H; Martinez, FP; Mdingi, MM; Mitchev, N; Peters, RPH; Shroufi, A | 1 |
| Dingle, TC; Ferrato, C; Gratrix, J; Ma, A; Martin, I; Smyczek, P | 1 |
21 review(s) available for ciprofloxacin and zithromax
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Conformation; Tetracyclines | 2016 |
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
Chancroid.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Chancroid; Ciprofloxacin; Erythromycin; HIV Infections; Humans | 1996 |
[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Ciprofloxacin; Clavulanic Acid; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Maximal Expiratory Flow-Volume Curves; Multicenter Studies as Topic; Penicillins; Placebos; Practice Guidelines as Topic; Prognosis; Recurrence; Respiratory Function Tests; Tetracycline; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
[Diagnosis and antibiotic treatment of reactive arthritis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Arthritis, Reactive; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clinical Trials as Topic; Diagnosis, Differential; DNA, Bacterial; Drug Therapy, Combination; Enteritis; Female; Humans; Male; Models, Theoretical; Polymerase Chain Reaction; Rifampin; Salmonella; Salmonella Infections; Sensitivity and Specificity; Tetracyclines; Time Factors; Urethritis; Uterine Cervicitis; Yersinia; Yersinia Infections | 2002 |
[Pathogenesis, diagnosis and therapy of Legionella infections].
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Aza Compounds; Azithromycin; Ciprofloxacin; Diagnosis, Differential; DNA, Bacterial; Fluoroquinolones; Humans; Incidence; Legionella; Legionella pneumophila; Legionellosis; Legionnaires' Disease; Levofloxacin; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Serotyping; Virulence | 2006 |
[Optimising antibiotic policies in the Netherlands. IX. SWAB guidelines for antimicrobial therapy in adults with acute infectious diarrhoea].
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Dysentery; Erythromycin; Evidence-Based Medicine; Humans; Netherlands; Practice Guidelines as Topic; Treatment Outcome | 2006 |
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2007 |
Pathological evidence of rhabdomyolysis-induced acute tubulointerstitial nephritis accompanying Legionella pneumophila pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Humans; Kidney; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Nephritis, Interstitial; Rhabdomyolysis; Rifampin | 2008 |
Traveler's diarrhea: a clinical review.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Humans; Hygiene; Irritable Bowel Syndrome; Risk Factors; Travel | 2015 |
Antimicrobial therapy of acute diarrhoea: a clinical review.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Cholera; Ciprofloxacin; Diarrhea; Dysbiosis; Dysentery, Bacillary; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Fidaxomicin; Gastroenteritis; Humans; Rifamycins; Rifaximin; Salmonella Infections; Shiga-Toxigenic Escherichia coli; Yersinia Infections | 2016 |
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Genotype; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillins | 2020 |
Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Bicarbonates; Cephalosporins; Cholera; Cholera Vaccines; Ciprofloxacin; Drinking Water; Drug Resistance, Bacterial; Endemic Diseases; Epidemics; Europe; Global Burden of Disease; Glucose; Humans; Idarubicin; Potassium Chloride; Prednisone; Ringer's Lactate; Sanitation; Sodium Chloride; Travel; Travel Medicine; Travel-Related Illness; Typhoid Fever; Typhoid-Paratyphoid Vaccines; Vidarabine | 2019 |
Nontuberculous mycobacterial infections in left ventricular assist device patients.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Device Removal; Fatal Outcome; Heart Failure; Heart-Assist Devices; Humans; Male; Meropenem; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Prosthesis-Related Infections | 2020 |
Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries? A systematic review.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Ciprofloxacin; Developing Countries; Doxycycline; Drug Resistance, Microbial; Drug Utilization; Female; Humans; Mass Drug Administration; Pregnancy; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
A short review of human exposure to antibiotics based on urinary biomonitoring.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biological Monitoring; Ciprofloxacin; Humans | 2022 |
Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; beta-Lactams; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria; Neisseria gonorrhoeae; Penicillin-Binding Proteins | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Infant; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Resistance in Enteric Shigella and nontyphoidal Salmonella : emerging concepts.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Colistin; Humans; Salmonella; Shigella | 2023 |
19 trial(s) available for ciprofloxacin and zithromax
| Article | Year |
|---|---|
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Campylobacter; Campylobacter Infections; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Resistance, Microbial; Enteritis; Female; Humans; Male; Military Personnel; Thailand; Travel; United States | 1995 |
Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Dysentery, Bacillary; Follow-Up Studies; Humans; Male; Middle Aged; Shigella | 1997 |
Comparative trial of azithromycin and ciprofloxacin in the treatment of gonorrhea.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Culture Media; Female; Gonorrhea; Humans; Male; Nausea; Neisseria gonorrhoeae; Single-Blind Method; Travel; Treatment Outcome; Vaginal Smears; Vertigo | 1997 |
Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chancroid; Ciprofloxacin; Double-Blind Method; Female; Haemophilus ducreyi; Humans; Male | 1998 |
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Female; HIV-1; Humans; Incidence; Injections, Intramuscular; Male; Metronidazole; Middle Aged; Penicillin G Benzathine; Prevalence; Sexual Behavior; Sexually Transmitted Diseases; Single-Blind Method; Uganda | 1998 |
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Humans; Male; Microbial Sensitivity Tests; Typhoid Fever | 1999 |
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group.
Topics: Ampicillin; Anti-Infective Agents; Azithromycin; Cefaclor; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sulbactam; Treatment Outcome | 1999 |
Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Double-Blind Method; Dysentery; Female; Humans; Male; Middle Aged | 1999 |
A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Ciprofloxacin; Doxycycline; Female; Follow-Up Studies; Gonorrhea; Health Resources; Humans; Sexually Transmitted Diseases, Bacterial; South Africa; Treatment Outcome | 2002 |
Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis.
Topics: Adolescent; Adult; Aged; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chronic Disease; Ciprofloxacin; Humans; Male; Middle Aged; Prostate; Prostatitis | 2003 |
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Azithromycin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Pelvic Inflammatory Disease; Prospective Studies; Tinidazole | 2003 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Therapy; Diarrhea; Double-Blind Method; Drug Resistance, Bacterial; Fluid Therapy; Humans; Male; Treatment Outcome; Vibrio cholerae; Vomiting | 2006 |
Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial.
Topics: Azithromycin; Child; Child, Preschool; Cholera; Ciprofloxacin; Humans; Treatment Failure; Vibrio cholerae | 2010 |
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study.
Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Prostatitis; Secondary Prevention | 2011 |
Periodical antibiotic treatment for the control of gonococcal and chlamydial infections among sex workers in Benin and Ghana: a cluster-randomized placebo-controlled trial.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Benin; Chlamydia Infections; Ciprofloxacin; Cross-Sectional Studies; Double-Blind Method; Female; Follow-Up Studies; Ghana; Gonorrhea; Humans; Prevalence; Sex Workers; Sexual Behavior; Surveys and Questionnaires | 2012 |
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Chemoprevention; Ciprofloxacin; Diarrhea; Double-Blind Method; Female; Healthy Volunteers; Human Experimentation; Humans; Male; Rifaximin; Young Adult | 2018 |
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Female; Humans; Male; Middle Aged; Paratyphoid Fever; Treatment Outcome; Typhoid Fever; United Kingdom; Young Adult | 2019 |
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Gonorrhea; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2021 |
Open Label Randomized Controlled Comparison of Three Alternative Regimes of Ciprofloxacin, Azithromycin and Cefixime for Treatment of Uncomplicated Typhoid Fever in Bangladesh.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cefixime; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 2021 |
335 other study(ies) available for ciprofloxacin and zithromax
| Article | Year |
|---|---|
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
Topics: 3T3 Cells; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Mice; Microsomes, Liver; Mixed Function Oxygenases; Molecular Structure; Substrate Specificity | 2001 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 2007 |
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae | 2008 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; Crohn Disease; Culture Media; Humans; Immunosuppressive Agents; Mercaptopurine; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Reagent Kits, Diagnostic | 2008 |
Antistreptococcal activity of AR-709 compared to that of other agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Streptococcus pneumoniae; Streptococcus pyogenes; Tetrahydrofolate Dehydrogenase; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
Topics: Aminopyridines; Anti-Bacterial Agents; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma fermentans; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Mycoplasma pneumoniae; Ureaplasma; Ureaplasma Infections | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Biofilms; Cefepime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; DNA-Binding Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; MutS DNA Mismatch-Binding Protein; Pseudomonas aeruginosa; Transcription Factors | 2009 |
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Species Specificity; Tetracycline; Ureaplasma; Ureaplasma Infections | 2009 |
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Comparative antipneumococcal activities of sulopenem and other drugs.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2009 |
Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.
Topics: Acanthamoeba castellanii; Animals; Anti-Bacterial Agents; Chlamydiales; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quinolones | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycoplasma hominis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolines | 2009 |
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
Topics: Microbial Sensitivity Tests; Mycoplasma genitalium; Polymerase Chain Reaction | 2009 |
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Escherichia coli; Escherichia coli Proteins; Genetic Complementation Test; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Neisseria meningitidis | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactamases; beta-Lactams; Blood Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Inhalation Exposure; Mice; Mice, Inbred BALB C; Models, Biological | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
In vitro activity of azithromycin against nontyphoidal Salmonella enterica.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Drug Resistance, Bacterial; Finland; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections | 2010 |
Different classes of antibiotics differentially influence shiga toxin production.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Ciprofloxacin; Escherichia coli; Escherichia coli O157; Shiga Toxin; Sulfamethoxazole; Trimethoprim | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Fusidic Acid; Neisseria gonorrhoeae | 2010 |
Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Ketolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Ontario; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
Topics: Amidohydrolases; Anti-Bacterial Agents; Benzodiazepinones; Binding Sites; Catalysis; Catalytic Domain; Crystallography, X-Ray; Drug Design; Gram-Negative Bacteria; Hydroxamic Acids; Microbial Sensitivity Tests; Structure-Activity Relationship; Zinc | 2011 |
Bioactive sesqui- and diterpenoids from the Argentine liverwort Porella chilensis.
Topics: Argentina; Biofilms; Diterpenes; Hepatophyta; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pseudomonas aeruginosa; Quorum Sensing; Sesquiterpenes; Sesquiterpenes, Guaiane | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Discovery of 4''-ether linked azithromycin-quinolone hybrid series: influence of the central linker on the antibacterial activity.
Topics: | 2011 |
Synthesis of novel 15-membered 8a-azahomoerythromycin A acylides: Consequences of structural modification at the C-3 and C-6 position on antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Structure-Activity Relationship | 2017 |
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Female; Hep G2 Cells; Humans; K562 Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship | 2017 |
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones | 2017 |
Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Ketolides; Microbial Sensitivity Tests; Molecular Structure; Oximes; Quinolones; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2019 |
Synthesis and structure-bactericidal activity relationships of non-ketolides: 9-Oxime clarithromycin 11,12-cyclic carbonate featured with three-to eight-atom-length spacers at 3-OH.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2019 |
Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
Topics: Anti-Bacterial Agents; Azithromycin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transcriptional Regulator ERG; Vancomycin-Resistant Enterococci | 2020 |
New
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Pyridines; Quinolones; Quorum Sensing; Zebrafish | 2022 |
Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery.
Topics: | 2022 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes.
Topics: Anti-Bacterial Agents; Azithromycin; Chemotaxis, Leukocyte; Ciprofloxacin; Drug Delivery Systems; Erythromycin; Growth Inhibitors; Humans; Microbial Sensitivity Tests; Neutrophils; Rifampin; Streptococcus pyogenes | 1992 |
A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide cultures.
Topics: Amikacin; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Erythromycin; Microbial Sensitivity Tests; Mycobacterium avium Complex | 1991 |
Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Topics: Amoxicillin; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia trachomatis; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Erythromycin; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Urethra | 1990 |
In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
Topics: Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Erythromycin; Haemophilus ducreyi; Neisseria gonorrhoeae; Norfloxacin | 1990 |
Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bacteroides fragilis; Ciprofloxacin; Disease Models, Animal; Erythromycin; Escherichia coli; Female; Liver; Male; Mice; Rats; Salmonella enteritidis; Staphylococcus aureus | 1990 |
AIDS intervention in Uganda.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clinical Trials as Topic; Costs and Cost Analysis; Female; Humans; Male; Sexually Transmitted Diseases; Uganda | 1995 |
Corticosteroid therapy for AIDS patients with Mycobacterium avium-intracellulare infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Azithromycin; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Humans; Male; Mycobacterium avium-intracellulare Infection; Prednisolone | 1994 |
Azithromycin resistance in Campylobacter jejuni and Campylobacter coli.
Topics: Azithromycin; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests | 1993 |
Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
Topics: Animals; Antimalarials; Azithromycin; Babesiosis; Ciprofloxacin; Clindamycin; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Mesocricetus; Organometallic Compounds; Quinine; Spiro Compounds; Survival Analysis | 1993 |
Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice.
Topics: Animals; Azithromycin; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Female; Mice; Microbial Sensitivity Tests; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1993 |
In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Fluoroquinolones; Giardia lamblia; Metronidazole; Microbial Sensitivity Tests; Quinolones | 1993 |
In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gonorrhea; Humans; Microbial Sensitivity Tests; Naphthyridines; Neisseria gonorrhoeae; Pefloxacin; Penicillins | 1995 |
Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cell Line; Ciprofloxacin; Drug Carriers; Liposomes; Macrophages; Mice; Microscopy, Electron; Microscopy, Video; Mycobacterium avium; Tuberculosis, Avian | 1995 |
Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Campylobacter; Campylobacter Infections; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Humans; Military Personnel; Thailand; Travel; United States | 1996 |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome | 1996 |
[Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Yersinia pseudotuberculosis | 1996 |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Epithelium; Female; Humans; Male; Pulmonary Alveoli | 1996 |
Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Adhesion; Ceftazidime; Cell Line; Chlorocebus aethiops; Ciprofloxacin; Escherichia coli; Fimbriae, Bacterial; Kidney; Microbial Sensitivity Tests; Regression Analysis | 1996 |
The Etest for antimicrobial susceptibility testing of Bartonella henselae.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bartonella henselae; Cats; Ciprofloxacin; Doxycycline; Erythromycin; Humans; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1996 |
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteroides fragilis; Chlamydia; Ciprofloxacin; Clarithromycin; Doxycycline; Enterobacter; Erythromycin; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae | 1997 |
Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
Topics: Acquired Immunodeficiency Syndrome; Agar; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Fluoroimmunoassay; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Nucleic Acid Hybridization; Rifabutin | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae | 1997 |
Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3-dibutylbarbituric acid) trimethine oxonol and flow cytometry.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefuroxime; Ciprofloxacin; Colony Count, Microbial; Escherichia coli; Flow Cytometry; Fluorescent Dyes; Isoxazoles; Microbial Sensitivity Tests | 1997 |
Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
Topics: 1-Naphthylamine; Anti-Infective Agents; Azithromycin; Bacterial Outer Membrane Proteins; Burkholderia cepacia; Cations; Ceftazidime; Cell Membrane Permeability; Ciprofloxacin; Clarithromycin; Fleroxacin; Fluorescent Dyes; Fluoroquinolones; Gentamicins; Magnesium; Microbial Sensitivity Tests; Microscopy, Electron; Novobiocin; Oxolinic Acid; Polysaccharides, Bacterial; Tobramycin | 1997 |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch | 1997 |
A plastid organelle as a drug target in apicomplexan parasites.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chloramphenicol; Ciprofloxacin; Clindamycin; Coccidiostats; DNA Replication; Gene Dosage; Humans; Plastids; Topoisomerase II Inhibitors; Toxoplasma | 1997 |
Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Escherichia coli; Humans; Microbial Sensitivity Tests; Salmonella; Shigella; Shigella dysenteriae; Thailand; Travel | 1998 |
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bites and Stings; Bites, Human; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Species Specificity; Wound Infection | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
Indirect inhibition by antibiotics of nucleotide and deoxynucleotide biosynthesis in Plasmodium falciparum.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Chloramphenicol; Ciprofloxacin; Deoxyribonucleotides; Doxycycline; Nucleotides; Plasmodium falciparum | 1998 |
Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Pseudomonas aeruginosa; Respiratory System; Staphylococcus aureus; Streptococcus pneumoniae | 1998 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Culture Media; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Propionibacterium acnes; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1999 |
National guideline for the management of donovanosis (granuloma inguinale). Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Contraindications; Doxycycline; Female; Genital Diseases, Female; Genital Diseases, Male; Gentamicins; Granuloma Inguinale; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Ulcer | 1999 |
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Breast Feeding; Ceftriaxone; Chancroid; Ciprofloxacin; Contraindications; Erythromycin; Female; Genital Diseases, Female; Genital Diseases, Male; Haemophilus ducreyi; Humans; Male; Pregnancy; Pregnancy Complications, Infectious; Ulcer | 1999 |
The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Ciprofloxacin; Culture Media; Dose-Response Relationship, Drug; Humans; Legionella pneumophila; Microbial Sensitivity Tests; Monocytes | 2000 |
Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Missouri; Neisseria gonorrhoeae | 2000 |
From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Hawaii; Humans; Missouri; Neisseria gonorrhoeae | 2000 |
The activity of antibiotics against Legionella pneumophila: in vitro and in vivo studies.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Ciprofloxacin; Humans; Legionella pneumophila; Legionnaires' Disease | 2001 |
[Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Child; Ciprofloxacin; Humans; Meningococcal Infections | 2001 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Guyana; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Prevalence; Saint Vincent and the Grenadines; Spectinomycin; Tetracycline Resistance; Trinidad and Tobago | 2001 |
[Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin].
Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Female; Humans; Male; Meningococcal Infections; Middle Aged; Sex Factors | 2000 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Health Behavior; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillinase; Penicillins; Prevalence; Spectinomycin; Tetracycline; Tetracycline Resistance; Trinidad and Tobago | 2001 |
Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Erythromycin; HL-60 Cells; Humans; Ketolides; Legionella pneumophila; Microbial Sensitivity Tests | 2002 |
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; beta-Lactams; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Quinolines | 2002 |
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States | 2002 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
Should we offer antibiotic prophylaxis post sexual assault?
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Female; Genital Diseases, Female; Humans; Metronidazole; Patient Acceptance of Health Care; Rape; Sexually Transmitted Diseases; Trichomonas vaginalis; Vaginosis, Bacterial | 2003 |
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Ciprofloxacin; Gemfibrozil; Humans; In Vitro Techniques; Listeriosis; Macrophages; Staphylococcal Infections; Subcellular Fractions; Verapamil | 2003 |
In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 2003 |
[Cat scratch disease].
Topics: Animals; Azithromycin; Bartonella henselae; Cat-Scratch Disease; Cats; Ciprofloxacin; Clarithromycin; Humans; Insect Vectors; Serologic Tests; Siphonaptera; Zoonoses | 2003 |
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Lymphoma, Large B-Cell, Diffuse; Macrophages; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Tumor Cells, Cultured | 2003 |
High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Cuba; Female; Genotype; Gonorrhea; Humans; Incidence; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Retrospective Studies; Serotyping; Spectinomycin; Tetracycline; Tetracycline Resistance; Urban Population | 2003 |
[New achievements in the diagnosis and treatment of disseminated urogenital chlamydiosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Ciprofloxacin; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Josamycin; Male; Ofloxacin; Radionuclide Imaging; Time Factors; Treatment Outcome | 2003 |
Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Egypt; Erythromycin; Female; Humans; Incidence; Infant; Male; Microbial Sensitivity Tests; Pediatrics; Probability; Rural Population; Sensitivity and Specificity | 2003 |
Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma hominis; Quinolines; Sampling Studies; Sensitivity and Specificity; Singapore; Tetracycline | 2004 |
Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Azithromycin; Blotting, Western; Carrier Proteins; Cell Line; Cell Survival; Ciprofloxacin; DNA; Drug Resistance; Drug Resistance, Multiple; Glutathione; Humans; Hydrogen-Ion Concentration; Ionophores; Macrophages; Microscopy, Confocal; Microscopy, Phase-Contrast; Monensin; Probenecid; Protons; Renal Agents; Sulfhydryl Compounds | 2004 |
In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Azithromycin; Chlorocebus aethiops; Ciprofloxacin; Coxiella burnetii; Doxycycline; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Q Fever; Vero Cells | 2004 |
Identification of 5-aminosalicylic acid, ciprofloxacin and azithromycin by abrasive stripping voltammetry.
Topics: Azithromycin; Ciprofloxacin; Electrochemistry; Electrodes; Graphite; Mesalamine; Oxidation-Reduction; Powders; Technology, Pharmaceutical | 2004 |
A pilot study on antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Nepal.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Nepal; Penicillins; Pilot Projects; Spectinomycin; Tetracycline | 2005 |
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2006 |
Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance; Female; Germany; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Prospective Studies; Tetracycline | 2006 |
Can chlamydial conjunctivitis result from direct ejaculation into the eye?
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Conjunctivitis, Inclusion; Doxycycline; Ejaculation; Eye; Female; Homosexuality, Male; Humans; Male; Metronidazole; Neisseria gonorrhoeae; Risk Factors; Sexual Behavior; Sexual Partners; Treatment Outcome; Urethra; Urethritis | 2006 |
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.
Topics: Anti-Infective Agents; Aza Compounds; Azithromycin; Bronchi; Cell Line; Ciprofloxacin; Cystic Fibrosis; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Fluoroquinolones; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Moxifloxacin; NF-kappa B; Phosphorylation; Quinolines; Tumor Necrosis Factor-alpha | 2007 |
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical | 2007 |
Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacterial Typing Techniques; Bronchi; Cells, Cultured; Ciprofloxacin; Epithelial Cells; Female; Fluoroquinolones; Haemophilus influenzae; Humans; Ketolides; Male; Moxifloxacin; Quinolines | 2007 |
Multidrug-induced erythema multiforme.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Levofloxacin; Methenamine; Ofloxacin; Piroxicam; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Algorithms; Androgen Antagonists; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Biomarkers, Tumor; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Plant Extracts; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Quinazolines; Retrospective Studies; Serenoa | 2007 |
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Androgen Antagonists; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Plant Extracts; Prostatitis; Quinazolines; Serenoa; Treatment Outcome | 2007 |
Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.
Topics: Anti-Bacterial Agents; Azithromycin; Bangladesh; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Humans; Microbial Sensitivity Tests; Sentinel Surveillance; Shigella; Species Specificity; Treatment Outcome | 2007 |
In brief: Meningococcal prophylaxis.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Meningococcal Infections; Meningococcal Vaccines; Minnesota; Neisseria meningitidis; North Dakota; Rifampin | 2008 |
Alternatives to ciprofloxacin use for enteric Fever, United kingdom.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever; United Kingdom | 2008 |
Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azithromycin; Base Sequence; Ceftazidime; Ciprofloxacin; DNA Primers; DNA, Bacterial; Gene Expression; Genes, Bacterial; Humans; Oligonucleotide Array Sequence Analysis; Opportunistic Infections; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Virulence | 2008 |
Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors.
Topics: Azithromycin; Ciprofloxacin; Enterohemorrhagic Escherichia coli; Escherichia coli O157; Gentamicins; Ketolides; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Shiga Toxin 2 | 2008 |
[Antibiotic resistance of bacterial strains in paediatric infections: there are resistance and resistance!].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria; beta-Lactamases; Cephalosporin Resistance; Cephalothin; Child; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nucleic Acid Synthesis Inhibitors; Shigella sonnei; Staphylococcus aureus | 2008 |
[Bacterial diarrheas and antibiotics: European recommendations].
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Campylobacter jejuni; Ceftriaxone; Child; Ciprofloxacin; Diarrhea; Dysentery, Bacillary; Escherichia coli Infections; Gastroenteritis; Humans; Salmonella Infections | 2008 |
The trials of the returning traveler: ciprofloxacin failure in enteric fever.
Topics: Adult; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; India; Male; Microbial Sensitivity Tests; Paratyphoid Fever; Recurrence; Salmonella paratyphi A; Travel | 2008 |
Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cerebellum; Chi-Square Distribution; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Escherichia coli Infections; Escherichia coli O157; Germ-Free Life; Mutation; Rec A Recombinases; Shiga Toxin 1; Shiga Toxin 2; Survival Analysis; Swine | 2009 |
Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.
Topics: Abnormalities, Drug-Induced; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bioterrorism; Ciprofloxacin; Doxycycline; Erythromycin; Female; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Primary Prevention; Registries; Retrospective Studies; Risk Assessment; Tennessee; Young Adult | 2009 |
Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Microbial Sensitivity Tests; Microscopy, Electron, Scanning | 2009 |
Toxoplasma gondii: a simple Real-time PCR assay to quantify the proliferation of the apicoplast.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clindamycin; Computer Systems; DNA, Protozoan; Electrophoresis, Agar Gel; HeLa Cells; Humans; Plastids; Polymerase Chain Reaction; Toxoplasma | 2009 |
Resistance trends in Neisseria gonorrhoeae in southwestern Ohio.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ohio; Tetracycline | 2010 |
[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionellosis; Microbial Sensitivity Tests; Naphthyridines | 2010 |
An anterior chamber toxicity study evaluating Besivance, AzaSite, and Ciprofloxacin.
Topics: Acetates; Animals; Anterior Chamber; Anti-Bacterial Agents; Azepines; Azithromycin; Ciprofloxacin; Corneal Opacity; Drug Combinations; Drug Delivery Systems; Female; Fluoroquinolones; Glaucoma; Intraocular Pressure; Male; Minerals; Rabbits; Random Allocation; Sodium Chloride; Trabecular Meshwork | 2010 |
Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.
Topics: Antimitotic Agents; Azithromycin; Carbamazepine; Carbanilides; Ciprofloxacin; Diphenhydramine; Doxycycline; Environmental Monitoring; Fluoxetine; Sewage; Soil; Tetracycline; Thiabendazole; Triclosan | 2010 |
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Enterotoxigenic Escherichia coli; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guatemala; Humans; India; Mexico; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Travel | 2011 |
Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
Topics: Anti-Infective Agents; Azithromycin; Brucella melitensis; Brucellosis; Ciprofloxacin; Doxycycline; Gentamicins; Humans; Microbial Sensitivity Tests; Peru; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Resistance to ampicillin, third-generation cephalosporins, ciprofloxacin, co-trimoxazole and azithromycin in clinical isolates of Salmonella enterica subsp. enterica from Germany: real problem or sporadic circumstance?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Germany; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella enterica; Salmonella Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Chronic Disease; Ciprofloxacin; Cohort Studies; Drug Therapy, Combination; Fluoroquinolones; Humans; Macrolides; Male; Prostatitis; Retrospective Studies | 2011 |
Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Spectinomycin; Tetracycline; Urban Population | 2011 |
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Chloramphenicol; Ciprofloxacin; Escherichia coli; Meropenem; Minocycline; Rifamycins; Rifaximin; Shiga Toxin 2; Thienamycins; Tigecycline | 2012 |
Management of macrolide-resistant Mycoplasma pneumoniae infection.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma | 2012 |
Ciprofloxacin resistant osteomyelitis following typhoid fever.
Topics: Adult; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Debridement; Drug Resistance, Microbial; Forearm; Humans; Male; Osteomyelitis; Radiography; Salmonella Infections; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2012 |
Suppurative granulomatous inflammation in the ileo-anal pouch.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Colitis, Ulcerative; Colonic Pouches; Female; Granuloma; Humans; Pouchitis; Proctocolectomy, Restorative; Young Adult | 2013 |
Campylobacter antimicrobial resistance in Peru: a ten-year observational study.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Feces; Humans; Microbial Sensitivity Tests; Peru; Prevalence | 2012 |
Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada, 2005 to 2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Longitudinal Studies; Molecular Epidemiology; Molecular Sequence Data; Multilocus Sequence Typing; Neisseria gonorrhoeae; Saskatchewan | 2012 |
Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriax
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Health Planning Guidelines; Humans; Latin America; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Assurance, Health Care; Retrospective Studies; Sentinel Surveillance; Surveys and Questionnaires | 2012 |
Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin.
Topics: Adult; Age Distribution; Anti-Infective Agents; Azithromycin; Cambodia; Ceftriaxone; Child; Child Mortality; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Haplotypes; Hospitals, Pediatric; Humans; Male; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Retrospective Studies; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2012 |
Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
Topics: Alleles; Anti-Infective Agents; Azithromycin; Cefixime; Cephalosporins; Chromosomes, Bacterial; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillins; Plasmids; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2013 |
Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A.
Topics: Abscess; Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Breast Diseases; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Infusions, Intravenous; Paratyphoid Fever; Recurrence; Salmonella paratyphi A; Suction; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Bullous hemorrhagic myringitis.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Blister; Ciprofloxacin; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Hemorrhage; Humans; Male; Otitis; Tympanic Membrane | 2013 |
Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacteremia; Cambodia; Child; Ciprofloxacin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Prevalence; Salmonella enterica; Salmonella Infections; Sequence Analysis, DNA; Young Adult | 2012 |
[Bacillary angiomatosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Anti-Bacterial Agents; Azithromycin; Bartonella quintana; Biopsy; Ciprofloxacin; Humans; Male | 2012 |
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality; Homosexuality; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sensitivity and Specificity; Sentinel Surveillance; Tetracycline | 2013 |
Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Burns; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Wound Infection | 2013 |
Rhodococcus equi granulomatous mastitis in an immunocompetent patient.
Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Azithromycin; Biopsy, Fine-Needle; Ciprofloxacin; Drug Therapy, Combination; Female; Granulomatous Mastitis; Humans; Immunocompetence; Magnetic Resonance Imaging; Radiography; Rhodococcus equi; Treatment Outcome | 2013 |
Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; France; Humans; Male; Microbial Sensitivity Tests; Morocco; Salmonella enterica; Salmonella Infections; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2013 |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; beta-Lactam Resistance; Cefixime; Ceftriaxone; Ciprofloxacin; Epidemiological Monitoring; Female; Gonorrhea; Humans; Incidence; Japan; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillin G | 2013 |
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult | 2013 |
Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Female; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Neisseria gonorrhoeae; Penicillins; Saskatchewan; Sequence Analysis, DNA; Spectinomycin; Tetracycline; Young Adult | 2014 |
Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Age Factors; Azithromycin; Biological Availability; Biopharmaceutics; Body Surface Area; Child; Child, Preschool; Ciprofloxacin; Drug Dosage Calculations; Humans; Indoles; Infant; Infant, Newborn; Ketoprofen; Models, Biological; Pediatrics; Permeability; Quinolizines; Risk Assessment; Solubility; Terminology as Topic; Voriconazole | 2014 |
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult | 2014 |
High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cervix Uteri; Ciprofloxacin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Prevalence; Quality Assurance, Health Care; Sex Workers; Specimen Handling; Uganda; Women's Health | 2014 |
Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Netherlands; Salmonella; Salmonella Infections; Travel; Typhoid Fever | 2014 |
Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Salmonella Infections; Salmonella typhimurium | 2014 |
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Promoter Regions, Genetic; Repressor Proteins; RNA, Ribosomal, 23S; Spectinomycin; Treatment Failure | 2014 |
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Neisseria gonorrhoeae; Prevalence; Russia; Spectinomycin; Young Adult | 2014 |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium; Mycobacterium Infections; Pyrazinamide; Radiography | 2014 |
Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanning, China, 2000 to 2012.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Azithromycin; beta-Lactamases; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin; Tetracycline | 2014 |
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Humans; Italy; Male; Neisseria gonorrhoeae; Penicillinase; Penicillins; Retrospective Studies; Tetracycline | 2014 |
Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Hungary; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Time Factors; Young Adult | 2014 |
Antibiotic susceptibility of periodontal Streptococcus constellatus and Streptococcus intermedius clinical isolates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Streptococcus; Streptococcus intermedius; Tetracycline Resistance | 2014 |
Phenotypic and genotypic characteristics of Vibrio cholerae O1 isolated from the Sierra Leone cholera outbreak in 2012.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cholera; Ciprofloxacin; Disease Outbreaks; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Microbial Sensitivity Tests; Sierra Leone; Tetracycline; Vibrio cholerae O1 | 2014 |
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; beta-Lactamase Inhibitors; Cardiovascular Diseases; Ciprofloxacin; Clarithromycin; Comorbidity; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Moxifloxacin; Risk; Taiwan | 2015 |
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance | 2014 |
In Vitro Anti-inflammatory and Immunomodulatory Effects of Ciprofloxacin or Azithromycin in Staphylococcus aureus-Stimulated Murine Macrophages are Beneficial in the Presence of Cytochalasin D.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Azithromycin; Ciprofloxacin; Cytochalasin D; Drug Therapy, Combination; Glutathione; Hydrogen Peroxide; Inflammation; Interferon-gamma; Interleukin-10; Interleukin-6; Macrophages; Male; Mice; Microbial Sensitivity Tests; Muramidase; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2015 |
Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Load; Biofilms; Ciprofloxacin; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Histocytochemistry; Kidney; Mice; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Bladder; Urinary Tract Infections | 2015 |
Australian gonococcal surveillance programme, 1 April to 30 June 2014.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Disease Notification; Drug Combinations; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2014 |
Where macrolide resistance is prevalent.
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Infant; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2015 |
Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Health Planning Guidelines; Humans; India; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin | 2015 |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2015 |
Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia.
Topics: Actinomycetales Infections; Adult; Anti-Infective Agents; Australia; Azithromycin; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rhodococcus equi; Treatment Outcome; Vancomycin | 2015 |
Invasive Salmonella Infections at Multiple Surveillance Sites in the Democratic Republic of the Congo, 2011-2014.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacteremia; beta-Lactamases; Child; Child, Preschool; Ciprofloxacin; Democratic Republic of the Congo; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella; Salmonella enteritidis; Salmonella Infections; Salmonella typhi; Salmonella typhimurium; Seasons; Young Adult | 2015 |
Gardnerella vaginalis: An overlooked pathogen in male patients?
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gardnerella vaginalis; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Male; Metronidazole; Recurrence; Sex Distribution; Urethritis | 2015 |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gene Expression; Gonorrhea; Humans; Isoxazoles; Male; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds; Tetracycline; Topoisomerase II Inhibitors; Urethritis | 2016 |
An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.
Topics: Adult; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Disease Outbreaks; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; England; Female; Gonorrhea; Heterosexuality; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Treatment Outcome | 2016 |
Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Epidemiological Monitoring; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2015 |
Antimicrobial and antifouling efficacy of urinary catheters impregnated with a combination of macrolide and fluoroquinolone antibiotics against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Catheter-Related Infections; Ciprofloxacin; Humans; Pseudomonas aeruginosa; Urinary Catheters; Urinary Tract Infections | 2016 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Probenecid; Public Health Surveillance | 2016 |
Viral and Bacterial Etiology of Acute Diarrhea among Children under 5 Years of Age in Wuhan, China.
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Campylobacter; Child, Preschool; China; Ciprofloxacin; Diarrhea; Doxycycline; Escherichia coli; Female; Humans; Infant; Infant, Newborn; Male; Salmonella | 2016 |
Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Germany, West; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Tetracyclines; Treatment Outcome | 2016 |
Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
Topics: Adult; Alleles; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gene Expression; Gonorrhea; Humans; Hungary; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Phylogeny; Porins; Prevalence; Spectinomycin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetracycline; Transferrin-Binding Protein B | 2016 |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella | 2016 |
Shigella flexneri with Ciprofloxacin Resistance and Reduced Azithromycin Susceptibility, Canada, 2015.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Ciprofloxacin; Coinfection; Drug Resistance, Bacterial; Dysentery, Bacillary; History, 21st Century; HIV Infections; Humans; Microbial Sensitivity Tests; Population Surveillance; Shigella flexneri | 2016 |
Surface plasmon resonance sensor for antibiotics detection based on photo-initiated polymerization molecularly imprinted array.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cross-Linking Reagents; Methacrylates; Molecular Imprinting; Ofloxacin; Penicillins; Polymerization; Succinates; Surface Plasmon Resonance; Ultraviolet Rays | 2016 |
[Donovanosis (granuloma inguinale)].
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Erythromycin; Granuloma Inguinale; Humans; Ofloxacin | 2016 |
Antimicrobial susceptibility to azithromycin among Salmonella enterica Typhi and Paratyphi A isolates from India.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteremia; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella paratyphi B; Salmonella typhi; Serogroup; Typhoid Fever | 2016 |
Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; South America; Tetracycline | 2017 |
Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.
Topics: Adsorption; Anti-Bacterial Agents; Antidepressive Agents; Azithromycin; Ciprofloxacin; Citalopram; Clarithromycin; Environmental Monitoring; Sewage; Slovakia; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical | 2017 |
WGS to predict antibiotic MICs for Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; England; Genome, Bacterial; Gonorrhea; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Tetracycline; United States; Whole Genome Sequencing | 2017 |
Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cats; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Dogs; Drug Resistance, Bacterial; Erythromycin; Fresh Water; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Pets; Poland; Poultry; Prevalence; Tetracycline; Water Microbiology | 2017 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
.
Topics: Annual Reports as Topic; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Public Health Surveillance | 2017 |
A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Fluorescence; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Oxazines; Xanthenes | 2017 |
Antimicrobial susceptibility in
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult; Zimbabwe | 2018 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; beta-Lactamases; Cephalosporins; China; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Neisseria gonorrhoeae; Penicillins; Repressor Proteins; Spectinomycin; Tetracycline | 2017 |
Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Contact Tracing; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gonorrhea; Hawaii; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Young Adult | 2017 |
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Resistance, Bacterial; England; Female; Gonorrhea; Humans; Lost to Follow-Up; Male; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Penicillins; Point-of-Care Testing | 2017 |
Travelers' Diarrhea and Other Gastrointestinal Symptoms Among Boston-Area International Travelers.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidiarrheals; Azithromycin; Boston; Ciprofloxacin; Diarrhea; Dysentery; Female; Gastrointestinal Diseases; Humans; Loperamide; Male; Middle Aged; Prospective Studies; Self Report; Travel; Young Adult | 2017 |
Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fimbriae Proteins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Polymorphism, Single Nucleotide; Repressor Proteins; Tetracycline | 2018 |
Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Northern Territory; Penicillins; Public Health Surveillance | 2017 |
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Developing Countries; Diarrhea; Dysentery; Humans; Levofloxacin; Military Personnel; Rifamycins; Rifaximin | 2017 |
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Female; Gonorrhea; Heterosexuality; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult | 2017 |
Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Australia; Azithromycin; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; New South Wales; Practice Guidelines as Topic; Shigella; Young Adult | 2017 |
Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Disease Transmission, Infectious; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Point-of-Care Systems | 2017 |
High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Point-of-Care Systems; Retrospective Studies; Saskatchewan; Spectinomycin; Young Adult | 2018 |
A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
Topics: Anti-Bacterial Agents; Azithromycin; California; Ceftriaxone; Ciprofloxacin; Costs and Cost Analysis; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Genotyping Techniques; Gonorrhea; Humans; Neisseria gonorrhoeae; Retrospective Studies | 2018 |
A Comparison of Real-Time Polymerase Chain Reaction Assays for the Detection of Antimicrobial Resistance Markers and Sequence Typing From Clinical Nucleic Acid Amplification Test Samples and Matched Neisseria gonorrhoeae Culture.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; False Positive Reactions; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity | 2018 |
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cervix Uteri; Ciprofloxacin; Female; Germany; Gonorrhea; Humans; Laboratories; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Rectum; Urethra; Vagina; Young Adult | 2018 |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Czech Republic; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough; Young Adult | 2017 |
Prevalence and Antibiotic Resistance Profiles of Campylobacter jejuni Isolated from Poultry Meat and Related Samples at Retail Shops in Northern India.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Campylobacter jejuni; Cephalothin; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Food Contamination; Food Microbiology; India; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Public Health; Tetracycline | 2018 |
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; India; Male; Microbial Sensitivity Tests; Nalidixic Acid; Recurrence; Salmonella typhi; Treatment Outcome; Typhoid Fever; Young Adult | 2018 |
Campylobacter jejuni transcriptional and genetic adaptation during human infection.
Topics: Animals; Azithromycin; Bacterial Proteins; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; Flagella; Foodborne Diseases; Gene Expression Regulation, Bacterial; Genetic Variation; Humans; Intestines; Membrane Proteins; Rifaximin | 2018 |
Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.
Topics: Adolescent; Anti-Bacterial Agents; Asthma; Azithromycin; Child; Chlamydophila Infections; Chlamydophila pneumoniae; Ciprofloxacin; Doxycycline; Female; Humans; Immunoglobulin E; Interferon-gamma; Interleukin-4; Leukocytes, Mononuclear; Male; Mycoplasma pneumoniae; Young Adult | 2018 |
First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Brazil; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult | 2018 |
Quality assurance for antimicrobial susceptibility testing of
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Epidemiological Monitoring; Gonorrhea; Humans; Laboratories, Hospital; Laboratory Proficiency Testing; Latin America; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Reproducibility of Results | 2018 |
Genetic characterisation of class 1 integrons among multidrug-resistant Salmonella serotypes in broiler chicken farms.
Topics: Animals; Azithromycin; Cefuroxime; Chickens; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Egypt; Integrons; Phylogeny; Salmonella; Salmonella enterica; Sequence Analysis, DNA; Serogroup; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Phenotypical resistance correlation networks for 10 non-typhoidal Salmonella subpopulations in an active antimicrobial surveillance programme.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Linear Models; Meat; Phenotype; Salmonella enterica; Salmonella Infections, Animal; Selection, Genetic; United States | 2018 |
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Female; Genotype; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny; Public Health Surveillance; Whole Genome Sequencing; Young Adult | 2018 |
Bioavailability of biosolids-borne ciprofloxacin and azithromycin to terrestrial organisms: Microbial toxicity and earthworm responses.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria; Biological Availability; Ciprofloxacin; Oligochaeta; Soil Microbiology; Soil Pollutants | 2019 |
Retention-release of ciprofloxacin and azithromycin in biosolids and biosolids-amended soils.
Topics: Adsorption; Anti-Bacterial Agents; Azithromycin; Biological Availability; Ciprofloxacin; Diffusion; Kinetics; Models, Theoretical; Soil Pollutants | 2019 |
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Yaoundé, Cameroon From 2009 to 2014.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cameroon; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Practice Guidelines as Topic; Sentinel Surveillance; Vagina | 2018 |
Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Ciprofloxacin; Conjunctiva; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Tobramycin; Trimethoprim; United States | 2018 |
Plant toxicity and accumulation of biosolids-borne ciprofloxacin and azithromycin.
Topics: Azithromycin; Ciprofloxacin; Festuca; Lactuca; Raphanus; Soil Pollutants | 2019 |
Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoeae isolates from men who have sex with men.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Repressor Proteins; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2019 |
Antibiotic Resistance of
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Tetracycline | 2019 |
Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cataract Extraction; Cefuroxime; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Ophthalmic Solutions; Postoperative Complications | 2018 |
Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014-2017.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cote d'Ivoire; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Prevalence; Sentinel Surveillance; Treatment Failure; World Health Organization; Young Adult | 2019 |
Risk assessment of biosolids-borne ciprofloxacin and azithromycin.
Topics: Agriculture; Azithromycin; Ciprofloxacin; Environmental Monitoring; Risk Assessment; Soil Pollutants; Waste Disposal, Fluid | 2019 |
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Europe; Female; Gentamicins; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin; Young Adult | 2018 |
Co-circulation of Multidrug-resistant Shigella Among Men Who Have Sex With Men in Australia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Child; Ciprofloxacin; Computational Biology; Drug Resistance, Bacterial; Female; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Mutation; Plasmids; Risk Factors; Sexually Transmitted Diseases; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination; Victoria; Whole Genome Sequencing; Young Adult | 2019 |
Comparison of Neisseria gonorrhoeae minimum inhibitory concentrations obtained using agar dilution versus microbroth dilution methods.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Culture Media; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Tetracycline | 2019 |
Identifying the mechanism underlying treatment failure for Salmonella Paratyphi A infection using next-generation sequencing - a case report.
Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Male; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi A; Treatment Failure | 2019 |
Antimicrobial Susceptibility Testing of
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Laos; Leptospira; Leptospirosis | 2019 |
Fate of antibiotics in three distinct sludge treatment wetlands under different operating conditions.
Topics: Anti-Bacterial Agents; Azithromycin; Biodegradation, Environmental; Ciprofloxacin; Environmental Monitoring; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Wetlands | 2019 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2018
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Public Health Surveillance | 2019 |
[From surveillance to action: Modifying therapeutic behaviours in gonococcal infections].
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Controlled Before-After Studies; Doxycycline; Female; Gonorrhea; Humans; Incidence; Male; Medication Adherence; Microbiology; Middle Aged; Neisseria gonorrhoeae; Physicians, Primary Care; Population Surveillance; Quinolones; Spain; Young Adult | 2020 |
UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Blood Chemical Analysis; Calibration; Cefotaxime; Child; Child, Preschool; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Limit of Detection; Male; Meropenem; Metronidazole; Pediatrics; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Trends and Risk Factors for Antimicrobial-Resistant
Topics: Adult; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neisseria gonorrhoeae; Risk Factors; Young Adult | 2019 |
An African Salmonella Typhimurium ST313 sublineage with extensive drug-resistance and signatures of host adaptation.
Topics: Adaptation, Physiological; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Cell Line; Ciprofloxacin; Democratic Republic of the Congo; Drug Resistance, Multiple, Bacterial; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Plasmids; Salmonella typhimurium; THP-1 Cells; Whole Genome Sequencing | 2019 |
Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Cystic Fibrosis; Drug Stability; Drug Storage; Expectorants; Horses; Mucus; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2019 |
In-vitro evaluation of a ciprofloxacin and azithromycin sinus stent for Pseudomonas aeruginosa biofilms.
Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Drug Liberation; Drug Stability; Drug Synergism; Drug-Eluting Stents; Microbial Sensitivity Tests; Nanoparticles; Polyesters; Pseudomonas aeruginosa | 2020 |
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2019 |
Haitian-like genetic traits with creeping MIC of Azithromycin in
Topics: Alleles; Anti-Bacterial Agents; Azithromycin; Cholera; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Gene Transfer, Horizontal; Genotype; Haiti; Humans; India; Microbial Sensitivity Tests; Mutation; Phenotype; Polymerase Chain Reaction; Sequence Analysis, DNA; Tetracycline; Vibrio cholerae O1 | 2020 |
Spread of multidrug resistance among
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Mutation; Phylogeny; Serogroup; Tunisia; Ureaplasma; Ureaplasma Infections | 2020 |
Antibiotic susceptibility of cultivable aerobic microbiota from the oral cavity of Echis carinatus from Odisha (India).
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Microbiota; Mouth; Penicillins; Phylogeny; RNA, Ribosomal, 16S; Viperidae | 2020 |
Effect of biosolids characteristics on retention and release behavior of azithromycin and ciprofloxacin.
Topics: Adsorption; Anti-Bacterial Agents; Azithromycin; Biosolids; Ciprofloxacin; Soil Pollutants | 2020 |
Environmental Risk and Risk of Resistance Selection Due to Antimicrobials' Occurrence in Two Polish Wastewater Treatment Plants and Receiving Surface Water.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Sewage; Sulfamethoxazole; Tandem Mass Spectrometry; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2020 |
Azithromycin susceptibility testing for Salmonella enterica isolates: discordances in results using MIC gradient strips.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; England; Humans; London; Microbial Sensitivity Tests; Salmonella enterica; Salmonella typhi | 2020 |
Non-typhoidal Salmonella bloodstream infections in Kisantu, DR Congo: Emergence of O5-negative Salmonella Typhimurium and extensive drug resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Congo; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Salmonella; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium; Serogroup; Typhoid Fever; Young Adult | 2020 |
Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro.
Topics: Analgesics; Azithromycin; Bartonella henselae; Biofilms; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Gentamicins; Methylene Blue; Microbial Sensitivity Tests; Microbial Viability; Nitrofurantoin; Rifampin | 2020 |
Changing Susceptibility Pattern of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Child; Cholera; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Female; Furazolidone; Hospitals, Special; Humans; Male; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O1 | 2020 |
Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale.
Topics: Anti-Infective Agents; Azacitidine; Azithromycin; Bacteria; Ciprofloxacin; Diet; DNA, Bacterial; Feces; Gastrointestinal Microbiome; Genome, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Metagenome; Middle Aged; Myelodysplastic Syndromes; Primary Myelofibrosis; RNA-Seq; Sequence Analysis, DNA | 2020 |
Australian Gonococcal Surveillance Programme Annual Report, 2019.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; History, 21st Century; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; New South Wales; Northern Territory; Penicillin Resistance; Penicillins; Population Surveillance; Queensland; Tasmania; Victoria; Western Australia | 2020 |
The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan Province, China.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Salmonella; Salmonella Infections; Serogroup; Young Adult | 2020 |
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Germany; Gonorrhea; Humans; Laboratories; Laboratory Proficiency Testing; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quality Control; Reference Standards; Surveys and Questionnaires | 2020 |
Azithromycin and ciprofloxacin inhibit interleukin-8 secretion without disrupting human sinonasal epithelial integrity in vitro.
Topics: Azithromycin; Ciprofloxacin; Epithelial Cells; Humans; Interleukin-8; Paranasal Sinuses; Sinusitis | 2021 |
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Real-Time Polymerase Chain Reaction | 2020 |
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Gonorrhea; Humans; Macrolides; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2021 |
Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Topics: Acetylcysteine; Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Ciprofloxacin; Curcumin; Cytokines; Drug Carriers; Drug Combinations; Drug Compounding; Expectorants; Freeze Drying; Humans; Inflammation Mediators; Macrophages; Microbial Viability; Mucus; Nanoparticles; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; THP-1 Cells; Tobramycin | 2020 |
Australian Gonococcal Surveillance Programme 1 July to 30 September 2020.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Public Health Surveillance | 2020 |
Evaluation of Combined Ciprofloxacin and azithromycin free and nano formulations to control biofilm producing Pseudomonas aeruginosa isolated from burn wounds.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Burns; Ciprofloxacin; Drug Therapy, Combination; Mice; Microbial Sensitivity Tests; Nanomedicine; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Prospective Studies; Sexual and Gender Minorities; Spain | 2021 |
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; European Union; Female; Gonorrhea; Heterosexuality; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sex Factors; Sexual and Gender Minorities; Sexual Behavior | 2021 |
Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; England; Genetics, Population; Genome, Bacterial; Genomics; Genotype; Geography; Global Health; Humans; Microbial Sensitivity Tests; Phylogeny; Polymorphism, Single Nucleotide; Shigella sonnei; United States; Whole Genome Sequencing | 2021 |
Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; Dysentery, Bacillary; Humans; Macrolides; Microbial Sensitivity Tests; Retirement; Shigella; Shigella sonnei; Treatment Outcome; Vermont | 2022 |
Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Codon; Dogs; Drug Resistance, Microbial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Luminescent Proteins; Microbial Sensitivity Tests; Red Fluorescent Protein; Tobramycin | 2021 |
Azithromycin and Ciprofloxacin Can Promote Antibiotic Resistance in Biosolids and Biosolids-Amended Soils.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Bacterial Proteins; Biosolids; Ciprofloxacin; Drug Resistance, Bacterial; Interspersed Repetitive Sequences; Soil; Soil Microbiology; Soil Pollutants | 2021 |
Emergence of Conjugative IncC Type Plasmid Simultaneously Encoding Resistance to Ciprofloxacin, Ceftriaxone, and Azithromycin in Salmonella.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Microbial Sensitivity Tests; Plasmids; Salmonella | 2021 |
Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Genetic Variation; Genome; Geography; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Sexually Transmitted Diseases; Shigella; Spain; Whole Genome Sequencing | 2021 |
Developing a model to predict individualised treatment for gonorrhoea: a modelling study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; England; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities; Wales | 2021 |
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Ertapenem; Gentamicins; Gonorrhea; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Neisseria gonorrhoeae | 2021 |
Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Complement Activation; Complement C4b-Binding Protein; Drug Resistance, Bacterial; Humans; Immunoglobulin M; Neisseria gonorrhoeae; Recombinant Fusion Proteins; Spectinomycin | 2021 |
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Gonorrhea; Humans; Malawi; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Polymorphism, Single Nucleotide; Spectinomycin; Tetracycline; Treatment Outcome | 2022 |
Dissemination and genome analysis of high-level ceftriaxone-resistant
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Genome, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Spectinomycin | 2022 |
Molecular Surveillance and Prediction of Antimicrobial Resistance of Neisseria gonorrhoeae in Northern Alberta, Canada, 2015 to 2018.
Topics: Alberta; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
Suspect screening of wastewaters to trace anti-COVID-19 drugs: Potential adverse effects on aquatic environment.
Topics: Azithromycin; Ciprofloxacin; COVID-19; COVID-19 Drug Treatment; Ecosystem; Environmental Monitoring; Humans; Pharmaceutical Preparations; SARS-CoV-2; Wastewater; Water Pollutants, Chemical | 2022 |
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Mitomycin; Neisseria gonorrhoeae; Qatar; Tetracycline | 2022 |
Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2021 |
Azithromycin can induce SOS response and horizontal gene transfer of SXT element in Vibrio cholerae.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; DNA Transposable Elements; Gene Transfer, Horizontal; SOS Response, Genetics; Tetracyclines; Vibrio cholerae | 2022 |
Antibiotic susceptibility of bacterial pathogens isolated from the aqueous and vitreous humour in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) Surveillance Study: 2009-2020 update.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophthalmitis; Haemophilus influenzae; Humans; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vitreous Body | 2022 |
Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Ciprofloxacin; Coinfection; Drug Resistance, Microbial; Female; Gabon; Humans; Infant, Newborn; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; Pregnancy; Prevalence; Tetracycline; Ureaplasma; Ureaplasma Infections; Ureaplasma urealyticum; Vaginosis, Bacterial | 2022 |
Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Gentamicins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin | 2022 |
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonorrhoeae; World Health Organization | 2021 |
Clinical and Genomic Investigation of an International Ceftriaxone- and Azithromycin-Resistant Shigella sonnei Cluster among Men Who Have Sex with Men, Montréal, Canada 2017-2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Genomics; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Phylogeny; Sexual and Gender Minorities; Shigella sonnei | 2022 |
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngitis; Sexual and Gender Minorities | 2022 |
[The postal code as a "bar code" of antimicrobial resistance].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2022 |
Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Ceftazidime; Child; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Humans; Levofloxacin; Meropenem; Piperacillin; Retrospective Studies; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Peru; Spectinomycin | 2022 |
Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sequence Analysis; Spectinomycin; Tetracycline; Thailand | 2022 |
Antibiotics in the Basque coast (N Spain): Occurrence in waste and receiving waters, and risk assessment (2017-2020).
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; COVID-19; Ecosystem; Environmental Monitoring; Fluoroquinolones; Humans; Penicillins; Risk Assessment; Spain; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2022 |
Australian Gonococcal Surveillance Programme Annual Report, 2021.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Neisseria gonorrhoeae; Northern Territory; Penicillins | 2022 |
Antibiotics in sewage treatment plants, receiving water bodies and groundwater of Chennai city and the suburb, South India: Occurrence, removal efficiencies, and risk assessment.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Environmental Monitoring; Erythromycin; Fluoroquinolones; Groundwater; India; Macrolides; Ofloxacin; Risk Assessment; Sewage; Sulfamethazine; Tetracyclines; Water; Water Pollutants, Chemical | 2022 |
Trends and regional variations of gonococcal antimicrobial resistance in the Netherlands, 2013 to 2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Netherlands; Sentinel Surveillance; Sexual and Gender Minorities | 2022 |
Predicting selection for antimicrobial resistance in UK wastewater and aquatic environments: Ciprofloxacin poses a significant risk.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; United Kingdom; Wastewater; Water Pollutants, Chemical | 2022 |
Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Emergency Service, Hospital; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Hospitals; Humans; Levofloxacin; Moxifloxacin; Norfloxacin; Retrospective Studies; Suicidal Ideation; Suicide; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
[Molecular characteristics of ciprofloxacin-cefotaxime-azithromycin co-resistant
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Quinolones; Salmonella; Salmonella enterica; Serogroup | 2022 |
Rapid emergence of extensively drug-resistant Shigella sonnei in France.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; France; Humans; Microbial Sensitivity Tests; Plasmids; Shigella sonnei | 2023 |
Direct toxicity of six antibiotics on soil bacterial communities affected by the addition of bio-adsorbents.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biomass; Ciprofloxacin; Clarithromycin; Soil; Soil Pollutants; Trimethoprim | 2023 |
Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2023 |
Genome-wide association studies reveal distinct genetic correlates and increased heritability of antimicrobial resistance in
Topics: Anaerobiosis; Anti-Bacterial Agents; Azithromycin; Cholera; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Genome-Wide Association Study; Humans; Oxygen; Vibrio cholerae | 2022 |
Pre-exposure to azithromycin enhances gonococcal resilience to subsequent ciprofloxacin exposure: an
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2023 |
Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Dysentery, Bacillary; Humans; Infant; Infant, Newborn; Mali; Microbial Sensitivity Tests; Shigella | 2023 |
Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities | 2023 |
Drug-Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cephalexin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Humans; Population Health; Retrospective Studies; United States | 2023 |
Antibiotic susceptibility pattern of Portuguese environmental Legionella isolates.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Doxycycline; Fluoroquinolones; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Portugal | 2023 |
Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016-2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Retrospective Studies; Spain | 2023 |
Stable isotope labeling as a promising tool for rapid drug susceptibility testing in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Culture Media, Conditioned; Isotope Labeling; Lysine; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Neisseria gonorrhoeae; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Sanguinarine, similar to the MICs of spectinomycin, exhibits good anti-Neisseria gonorrhoeae activity in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin | 2023 |
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Genomics; Gonorrhea; Humans; Malawi; Microbial Sensitivity Tests; Neisseria gonorrhoeae; South Africa; Tetracycline; Uganda | 2023 |
Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefuroxime; Ciprofloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Antimicrobial susceptibilities and genomic epidemiology of Neisseria gonorrhoeae in Stockholm, Sweden.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Genomics; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Sweden | 2023 |
Correlates of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quebec; Sentinel Surveillance; Sexual and Gender Minorities | 2023 |
Genetic characterization of a Salmonella enterica serovar Typhimurium isolated from an infant with concurrent resistance to ceftriaxone, ciprofloxacin and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant; Multilocus Sequence Typing; Salmonella typhimurium; Serogroup | 2023 |
Australian Gonococcal Surveillance Programme Annual Report, 2022.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Population Surveillance; Rural Population | 2023 |
Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Mycobacterium tuberculosis; Neisseria gonorrhoeae; Penicillin G; South Africa; Tetracycline | 2023 |
Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of
Topics: Agar; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Retrospective Studies; Tetracycline | 2023 |